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The treatment and/or prevention of cancer by selective down regulation of cancer
causing gene (oncogene) transcription would represent a significant advance in the area
of anticancer drug design. Non-canonical higher order DNA structures formed in
oncogene promoter regions are novel targets for the modulation of oncogene expression.
An obvious advantage of selectively targeting oncogene expression would be that general
cytotoxicity would be minimized and the negative side effects of current chemotherapy
approaches could be minimized or eliminated. To provide a foundation for the design of
drugs that target oncogene promoter G-quadruplexes and i-Motifs, the basic
understanding is required of the folding of guanine and cytosine rich sequences and how
small molecules bind to these structures.
The research reported here focuses on higher order DNA structures of two
oncogenes, K-ras that is overexpressed in pancreatic cancer, and Bcl-2 that is
overexpressed in a number of cancers, and one non-oncogene, HAR1. We have probed
the overall structure, stability, and binding of a model drug compounds to G-quadruplex
and i-Motif DNA structures in these genes. The overall objectives of this work were: 1)
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to understand the relationship between oligonucleotide sequence and intramolecular
folding topology and stability, and 2) to understand the mechanisms for the selective
binding of small molecules to these structures. Biophysical techniques including:
microcalorimetry, spectroscopy, analytical ultracentrifugation, gel electrophoresis, and
computational methods were used to characterize both the folding and the binding
interactions.
We have shown that the native K-ras purine and pyrimidine rich sequences form
stable G-quadruplexes and i-Motifs. We have also characterized four G-rich sequences
found within the reading frame of the human HAR1 gene. This is the first report on the
formation of stable G-quadruplex motifs within the RF of any gene. The model drug,
TMPyP4, binds to the Bcl-2, K-ras, and HAR1 G-quadruplexes by two different binding
modes, end binding and intercalation.
The significance of this research is that the results of the K-ras and Bcl-2 studies
could lead to the design of drugs that selectively target oncogenes while the HAR1 results
could provide new approaches to the treatment of Schizophrenia and Alzheimer’s
disease.
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CHAPTER I
INTRODUCTION
Rational drug design begins with choosing a target. From the perspective of the
fundamental central dogma depicted in Figure 1.1 there are a number of unique targets
for anti-cancer drug design. Each of the processes in the flow of genetic information
from DNA replication, DNA transcription to RNA, and RNA translation to protein there
are number of pathways and individual products that can be exploited for the treatment of
cancer. In the process of DNA transcription for example, 1) the DNA that is being
transcribed, 2) the transcription machinery (i.e. proteins), or 3) the RNA transcripts
themselves are all viable targets for selective drug design (1).

Figure 1.1

The central dogma of molecular biology, first described by Francis Crick in
1970.

One of the most common tools for diagnosing cancer involves the final product of
the central dogma flow of information, proteins. Monitoring expression levels of
specific translated proteins, for example testing for specific cancer “biomarkers”, is
frequently used to establish the presence or absence of cancer in the human body. The
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targeting of these quantitatively measured translated proteins however is not
advantageous with respect to anticancer drug design. There are a number of issues
associated with the targeting of proteins themselves. In most cancers the expression
levels of various proteins may be altered and therefore an exponentially large number of
proteins may be translated, therefore specifically targeting a large number of molecules
could be difficult for a number of reasons. Another reason the targeting of a specific
protein may be problematic is that a number of the overexpressed proteins found in
cancer cells are often mutated or altered from their native states so the drug resistance or
ineffectiveness may be an issue (2, 3). The most important issue, from the view of
molecular and cellular biology, is that the native protein may be involved in other critical
pathways for cell survival and therefore targeting it may produce unwarranted side effects
such as those seen with current chemotherapeutic treatments to include (but not limited
to) hair loss, weight loss, loss of vision, etc. (2, 3).
The aforementioned issues with targeting individual proteins for anticancer drug
design can also be expanded to the targeting RNA transcripts or the DNAs themselves.
Recent reports have indicated that not all functions of non-protein coding RNA sequences
have been elucidated (4-6). There are a number of siRNA and microRNA transcripts that
are non-protein coding RNA sequences that are implied in various reaction pathways in
healthy human cells (7). In some cancers the mRNA transcript levels are increased
whereas the protein expression levels remain unchanged (5, 8, 9). Similarly to proteins
these mRNA transcripts may be involved in other reaction pathways; i.e. a single mRNA
can code for more than one protein and may be important in an additional critical
pathway. Drugs that inhibit DNA replication by targeting specific replication machinery
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or DNA itself are not advantageous because they can often effect the replication of DNA
in non-cancerous cells.
Ultimately, the development of drugs that target nucleic acid (DNA) structures for
transcriptional regulation has been an area of increasing interest for anticancer drug
design (10). Previous studies regarding the targeting of DNA for transcriptional
regulation have focused on sequence specific ligands. These ligands have been shown to
downregulate transcription by a number of interactions including binding to transcription
factor binding sites and/or blocking of transcription factor/DNA interfaces. A number of
these well characterized small molecules include DNAminor groove binding ligands (11,
12), duplex intercalative agents (13-15), and short oligomeric aptamers (16, 17). These
studies have provided a great foundation for the interactions of small molecules and
DNA, however the sequence homology amongst a number of genes demonstrates that
these ligands often lack sequence or gene selectivity. Numerous studies indicate current
cancer research is shifting towards a more promising focus of structurally specific, rather
than sequence specific, area of drug design (18-21). Specifically targeting structures that
are represented in cancer cells and not healthy cells would address the issues of toxicity
and other undesirable side effects of current cancer chemotherapies. Therefore the
primary goal of cancer chemotherapeutics of designing drugs that target specific higher
order DNA structures could be crucial in the transcriptional regulation of cancer genes.
There are a number of well-documented higher order structures that can be
formed by DNA to include: hairpins, cruciforms, triplexes, G-quadruplex motifs, and iMotifs. Approximately 40% of all human genes have been found to have i-Motif
forming purine and G-quadruplex forming pyrimidine-rich sequences within (18, 22)
their promoter regions (23). The promoter region, shown in Figure 1.2, has a particular
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DNA sequence and response elements that facilitate transcription by associating with a
number of polymerases and transcription factors.
The promoter region is typically located within the coding strand (sense strand)
and is upstream in the 5’ direction to the gene it regulates. There are several levels of
transcriptions within a cell that can be summarized by two states: basal and activated.
Basal transcription is the constitutive transcription of a given gene, which in a normal cell
can fluctuate from high to low levels depending on the cells’ state and a given process
occurring within the cell. An activated transcription level is one where the level of
transcription increases to a constant level above or below these constitutive levels,
essentially being described as “turned on” or “turned off.”

Figure 1.2

A schematic representation of the transcription process including the
promoter region, the RNA polymerase bound to the DNA, the mRNA
transcript, and the single strand of DNA that is being transcribed.

By definition a proto-oncogene is a gene that when mutated or
over/underexpressed can become an oncogene. An oncogene is a gene that implied in or
has the potential to cause cancer. When these genes are “turned on” or “turned off” the
result can be any number of cancers. Of the oncogenes classified, a number of them can
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be classified further regarding their specific functions as transcription factors, growth
factors, growth factor receptors, signal transducers, and apoptosis and senescence factors.
One gene of particular interest from the perspective of cancer treatment and possible
prevention is the c-MYC oncogene which is over-expressed in 60-80% of all cancers (18,
19, 24-28). The c-MYC proto-oncogene, under normal transcription regulation, codes for
the protein c-Myc that assists in the regulation of gene transcription (26). Some common
biological effects observed from the overexpression of the c-MYC are cell proliferation,
cell growth, and inhibition of apoptosis (29). Previous studies have established that the
overexpression of the c-MYC oncogene is associated with a large number of human
cancers including colon, cervical, breast, small-call lung, myeloid leukemias,
glioblastomas and osteosarcomas but is at a relatively low concentration in healthy
tissues (25, 26, 29). Overexpression of the c-MYC gene can occur through point
mutations, upregulation of transcription, and most commonly chromosomal translocation
(25, 26, 30-33). The nuclease hypersensitivity element IIII, NHEIIII (P1 promoter), is
one of multiple promoter sites found within the c-MYC gene and is responsible for 8590% of c-MYC transcription (18, 34). The NHEIIII region is highly purine (guanine) and
pyrimidine (cytosine) rich and has been reported to fold into higher order G-quadruplex
and i-Motif structures (25-27, 34, 35).
Because of the duplex nature of DNA in vivo, investigating only the single
stranded G-quadruplex structure represents an incomplete picture of the biologically
relevant gene promoter target. We recently reported the results of a computational study
in which theoretical structures for the c-MYC nuclease hypersensitivity element (NHE)
and c-MYC-NHE complexes with TMPyP4 were described (34). The complete NHE was
proposed as a new target for drug binding as it provides new binding pockets in the
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interface between the G-quadruplex and i-Motif components. To better understand gene
regulation, the biochemistry and biophysics of the G-quadruplex polypurine or i-Motif
forming polypyrimidine strand (36, 37) of the oncogene promoter regions must be better
characterized.
The G-quadruplex forms as a result of Hoogsteen hydrogen bonding between four
guanines and is not exhibited in typical duplex DNA. This hydrogen bonding lattice
between the four guanines is termed as a G-quartet or a G-tetrad as seen below in Figure
1.3.

Figure 1.3

The left panel depicts the Hoogsteen hydrogen bonding between four
guanine bases. The right panel depicts the G-quartet or G-tetrad that is
comprised of the four Hoogsteen hydrogen bonded guanines (38).

These tetrads stack on one another to form the G-quadruplex structure and are
stabilized by the π-π interactions. Based upon the sequence a number of conformations,
or an ensemble of structures, can exist in solution. The relative number of G-quadruplex
motifs found in equilibrium in solution depends on the number and location of the
guanines in the sequence (>3 adjacent, >2 with a kink), the orientations of sequence(s) to
one another (parallel vs. antiparallel, vs. mixed) and the conformations of each base (syn
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vs. anti) (28, 35). It should be noted that in the WT c-MYC P1 promoter sequence there
are 6 runs of guanines that may be involved in a G-quadruplex structure therefore there
are a number of structurally unique conformers that may be present in equilibrium in
dilute solutions. Figure 1.4 demonstrates three examples of possible folding topoligies for
the G-quadruplex structures that are termed antiparallel, parallel, or mixed
(antiparallel/parallel) based upon the direction of the sequence (from 5’ to 3’) in the
cormer backbone of the structure in reference to itself.

Figure 1.4

Demonstrates three of the sequence backbone folding topologies for the Gquadruplex antiparallel (left panel), parallel (center panel) and a mixed
parallel/antiparallel hybrid (right panel) (38).

A G-quadruplex exhibiting an antiparallel folding topology (following the arrows
for Figure 1.6) from 5’ to 3’ goes down- end loop-up-end loop-down-end loop up (Downup-down up). The orientation of the sequence in comparison to itself is not consistently
in the same direction. A G-quadruplex exhibiting a parallel folding topology as the
sequence in the corner backbone all facing the same direction whereas a mixed
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parallel/antiparallel has either 3 or 1 of the backbone strands parallel or antiparallel to the
direction of the rest of the sequences.
The most relevant structure for the studies described here are those which are
formed from a DNA strand also termed intramolecular G-quadruplexes, as seen in Figure
1.5. Intermolecular G-quadruplexes form by the interaction of 2 or more G-rich
sequences. The interaction between two individual G-rich sequences would therefore be
called a dimer or an intermolecular G-quadruplex, a four stranded G-quadruplex tetramer,
and >4 DNA sequences can form multiple complexes known as G-wires, as depicted in
Figure 1.5.

Figure 1.5

Schematic representation of intermolecular versus intramolecular Gquadruplex structures. Intermolecular structures are comprised of two or
more guanine rich strands to form a G-quadruplex structure. The left panel
shows a tetrameric parallel stranded intermolecular G-quadruplex
comprised of 4 individual g-rich strands. The center panel shows a dimeric
intermolecular antiparallel stranded G-quadruplex comprised of two
independent G-rich strands. The right panel shows an intramolecular
antiparallel stranded G-quadruplex that is comprised of a single G-rich
sequence (38).

8

The i-Motif is the cytosine rich complimentary strand to the G-quadruplex. It is
also a non-Watson-Crick tetramer of equivalent strands that are essentially “zipped”
together forming intercalated C•C+ as seen in Figure 1.6 (39).

Figure 1.6

The figure on the left depicts an intramolecular i-Motif structure with six
(C•C+ ) pairs in its core. The figure on the right depicts the
hemiprotonation (C•C+ ) between a single cytosine base pair.

To date, the majority of the studies on i-Motif DNA have focused on the
formation and stability of a few model intermolecular and intramolecular i-Motif
structures (36, 37, 40-45). These studies have been successful in characterizing the
folding patterns of i-Motif structures using NMR (42, 46-48), X-ray crystallography (43,
49), or other spectroscopic techniques (44). Sequences have been identified that favor the
formation of intramolecular i-Motif structures (40, 45, 50-54). A recent NMR study by
Dai et al. demonstrated that a mutant human c-MYC P1 polypyrimidine promoter
sequence can adopt at least two different intramolecular i-Motif structures (55). A few
studies have explored the impact of solution conditions (e.g. pH, cation, etc.) on the
formation and stability of intramolecular i-Motif structures (35, 36, 47, 49, 56, 57). All of
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these studies suggest that formation of an intramolecular i-Motif is favored at slightly
acidic pH where the cytosines are hemi-protonated (cytosine N3 pKa~4.58) (58).
Another notable oncogene whose G-quadruplex and i-Motif structures have been
well documented is Bcl-2. The Bcl-2 (B-cell CLLymphoma 2) proto-oncogene is
responsible for the transcription of the Bcl-2 protein that is a mitochondrial membrane
protein. The Bcl-2 protein’s primary function is to inhibit apoptosis and regulate or
program cell death. Primarily, the Bcl-2 proto-oncogene is overexpressed due to
chromosomal translocations and point mutations to a lesser extent(29, 59-61). Unlike cMYC, when Bcl-2 is over-expressed a noticeable reduction in cell death is observed.
Rather than increasing cell proliferation or impairing differentiation the mutated, or
cancerous, cells evade programmed cell death. The Bcl-2 proto-oncogene has been
demonstrated to be over-expressed in numerous cancers to include; B-cell and T-cell
lymphomas, breast, cervical, non-small cell lung and prostate cancer. Bcl-2 is also
different from both c-MYC and K-ras because it interferes with the various
chemotherapeutic treatments in that the apoptosis of the cell is restricted (29). This
unique attribute makes the Bcl-2 a promising target for anti-cancer drug design once
over-expressed(29, 62).
It has been demonstrated that expression of several oncogenes has been
downregualted by the binding of small molecules to the G-quadruplex or i-Motifs found
within their promoter regions. Though the equilibrium lies towards the duplex form of
this region, binding a drug with high affinity for G-quadruplex or i-motif DNA can drive
this equilibrium toward the formation of these higher order structures (26, 61, 63, 64).
When the G-quadruplex and i-Motif are formed they have been shown to inhibit the
binding interactions of proteins involved in transcriptional activation of several
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oncogenes, essentially “silencing” its expression, as depicted in Figure 1.7 (25-27, 34,
35).

Figure 1.7

Diagram of the c-MYC NHE-III1 (nuclease hypersensitivity element III1)
“silencer” element, showing the equilibrium between the transcriptionally
inactive and active forms. On the left is the transcriptionally inactive form,
containing both the G-quadruplex and i-Motif structures. On the right, is
the transcriptionally active form, with multiple transcription factors bound.

One of the most significant problems, and an area of much debate, when
designing drugs for oncogene regulation, is the uncertainty of whether or not the Gquadruplex and i-Motif higher order structures are biologically relevant or exist at all
under human physiological conditions (18, 27, 65, 66). However, it has been established
that binding a drug with high affinity for G-quadruplex drives the folding structural
equilibrium in the direction of G-quadruplex formation (18, 67). Hurley et al. reported
on the use of topoisomerase II inhibitors that interact with G-quadruplexes as well as
subsequent studies that show TMPyP4 is able to further stabilize the G-quadruplex
structure and suppress any further c-MYC transcriptional activation (26, 64, 68, 69).
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There are a number of small molecules and proteins which have shown to bind
with high affinity and selectivity for G-quadruplex and i-Motif DNA . The affinity of
cationic porphyrins, especially the model drug mesotetra (N-methyl-4-pyridyl) porphine
(TMPyP4), for G-quadruplex and i-Motif DNA has been previously established (69-74).
The structures of the cationic porphyrins TMPyP2, TMPyP3, and TMPyP4 are shown in
Figure 1.8. The overall mechanisms in which these compounds bind to G-quadruplex
and i-Motif DNA has been a topic of great dispute in the current literature.

Figure 1.8

Structures of the cationic porphyrins TMPyP2, TMPyP3, and TMPyP4,
TMPyP2 and TMPyP3 exhibit a non-planar geometry as a result of the
location of the N+-CH3 substituent. TMPyP4 exhibits a planar geometry
therefore it is able to intercalate between two G-tetrads.

We have reported previously that TMPyP4 binds model G-quadruplexes by two
different binding modes, an end binding mode and a weaker mode resembling
intercalation. This dissertation will provide new insight into the origin of porphyrin/Gquadruplex DNA interactions, including the influence of ligand geometry and the
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influence of the intramolecular DNA folding topology on the thermodynamics for these
interactions (18, 34, 75).
Recently a floroquinoline derivative, CX-3453 (Quarfloxin, Cylene
Pharmaceuticals), was the first G-quadruplex specific anti-cancer agent to be accepted
into Phase II of clinical trials (76). Quarfloxin was derived from a topoisomerase II
poison that also exhibited G-quadruplex selectivity reported by the Hurley group (76).
Cylene pharmaceuticals improved the selectivity for G-quadruplex DNA and by doing so
eliminated the topoisomerase II activity, therefore limiting the toxic side effects (76).
Quarfloxin inhibits the transcription of DNA in the nucleoli of cancerous cells by
specifically binding to G-quadruplexes formed in the rDNA. Quarfloxin is only one
example of how selectively exploiting G-quadruplex and i-Motif structures that are only
found within cancer cells can improve anti-cancer drug design and reduce non-specific
toxic interactions.
To date however, biophysical studies have been limited to short single-stranded
DNA sequences as models for the stability and the structure of the G-quadruplex that
may form in the promoter regions of several oncogenes. The model promoter region
sequences have shown the potential to fold into multiple unique sequence conformations
(18, 24, 25, 69, 77). The structural diversity and conformational equilibrium exhibited by
these sequences is the source of one of the most significant problems in drug targeting Gquadruplex (and/or i-Motif) structures, i.e. what is the most relevant target structure? In
order to design a small molecule having very high affinity and selectivity for the c-MYC
promoter region, we must know the structures of each of the receptor G-quadruplexes or
at least the structure of the most significant target conformation. Previous studies have
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attempted to determine the number and distribution of structural conformers
simultaneously existing in dilute solution using multiple techniques (69, 77, 78).
The studies reported in this dissertation were constructed to expand the
understanding of the structure and function of higher order DNA structures and their
interactions with small molecules. The results reported in this dissertation will
potentially lead to the design of new and better G-quadruplex and i-Motif selective drugs.
We have previously reported on the well characterized c-MYC and Bcl-2 G-quadruplex
and i-Motif structures. Here we expand the scope of our biophysical studies to include
more complicated binding models as well as study novel, less characterized, genes to
include the K-ras oncogene and the human HAR1 gene.
The K-ras oncogene is of great research interest because the overexpression of the
K-ras oncogene is associated with cancers that are more aggressive and have shorter
survival rates such as lung, breast, prostate, colorectal, skin, and most of all pancreatic
cancer(79, 80). The one year survival rate of a patient with pancreatic cancer is less than
20% and five year survival rate less than 5% which establishes it as the fourth leading
cause of cancer related deaths in the United States(80, 81). K-ras has been shown to be
mutated in greater than 90% of all pancreatic cancer incidents and is an attractive target
for understanding the role in which genetic mutations play in the development of
pancreatic cancer as well as others(80-82).
HAR1 is a non protein coding region that has two reading frames: HAR1F
(Forward) and HAR1R (reverse). Each of these reading frames produce mRNA
transcripts that do not exhibit any preMicroRNA function or have complete sequence or
structure homology to any other RNA transcripts. The exact role of HAR1F and HAR1R
are currently unknown however they’re expression is predominantly observed only in
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brain tissues and not seen in any other major organs or tissues. A number of human brain
malignancies, specifically ones that stem from the cerebral cortex, have recently
demonstrated altered expression of the HAR1 gene mRNA transcripts. Limited
information is available as to the exact role or mechanism by which the HAR1 gene
regulates or is involved in cerebral cortex formation and function but we have discovered
a number of G-rich sequences within the HAR1 gene reading frame that may form
intramolecular G-quadruplex structures. The discovery of these G-quadruplex structures
within the HAR1 reading frame may lead to the targeting of these structures for the
development of new drugs that can regulate gene transcription in human brain diseases.
General Outline
We used our previous knowledge of the c-MYC G-quadruplex and i-Motif
equilibria as a reference to solidify our understanding of the equilibrium between the
folded structures in these novel genes. In this work we probe the overall structure,
stability, and binding of small molecules to the sequences from various oncogene
promoter regions (K-ras and Bcl-2) as well as the first reported study on the role of these
structural motifs within non-oncogene reading frames (HAR1). Chapter 2 of this
Dissertation outlines the materials and methods used throughout each of these studies.
Chapter 3 focuses on the purine rich sequence of the Bcl-2 P1 promoter region and it’s
interaction with various porphyrin ligands.
The focus is shifted from the Bcl-2 Promoter regions G-quadruplex forming
sequences to a more complicated and unique system in Chapters 4 and 5. Chapters 4 and
5 describe the purine rich sequence found within the P1 promoter of the K-ras oncogene.
These studies are some of the first reported on the K-ras oncogene and include the
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characterization of the ensemble of G-quadruplex motifs formed by this sequence.
Chapter 6 focuses on the pyrimidine rich sequence of the K-ras P1 promoter region which
prior to this dissertation there are no reports on the structure or stability of this sequence
Chapter 7 consists of preliminary studies on several purine rich regions found
within the HAR1 gene reading frame. These studies are the first of their kind not only in
regards to the HAR1 gene but in regards to G-quadruplex forming regions in the gene
reading frame as opposed to the promoter region.
The final chapter of this Dissertation will summarize the results obtained
throughout these biophysical studies and will highlight some of the interesting and
overarching concepts discussed in each of the chapters.
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CHAPTER II
MATERIALS AND METHODS
This entire dissertation is centered on a number of nucleic acid models for
promoter region and gene reading frame G-quadruplex and i-motifs. This chapter is a
collective description of the biophysical tools commonly employed throughout each of
these studies. A brief description of the instrument, theory, and the experimental
methods are described in a single chapter to avoid repeating of each of these techniques
throughout each chapter. A more in depth description of some of these techniques, where
necessary, is provided in each respective chapter.
Differential Scanning Calorimetry
The primary biophysical technique used throughout all of the studies in this
dissertation was Differential Scanning Calorimetry (DSC). DSC is a powerful technique
that measures the cooperative melting of macromolecules to include (but not limited to)
nucleic acids and proteins (1-5). A DSC instrumental schematic is shown in Figure 2.1.
The DSC is made up of two independent cells that are isolated, shielded, and their
temperatures controlled by a small power source. One cell contains the macromolecule
and the other cell contains a reference solution such as water or buffer. There are
temperature sensors that provide feedback regarding the ΔTm between the sample and
reference cells as well as a sensor that monitors the ΔTm between the cells and the shield
(3, 6).
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Figure 2.1

Representative diagram of a typical DSC including the sample and
reference cells.

The difference in heat required to increase the temperature of a sample cell versus
a reference cell is measured as a function of temperature (3, 7). When the sample cell,
containing for instance DNA, undergoes a physical transformation (higher order folded
structure→single stranded random coil) more or less power will flow to the sample cell in
comparison to the reference (which increased at a constant temperature). The raw excess
heat capacity, or the data output is given in ucal/sec which is the differential power
response of the heater. In an exothermic process less power (heat) is supplied to the
sample cell to maintain a constant temperature between the sample cell and the reference
over time whereas in an endothermic process more power (heat) is supplied to the sample
cell to keep the sample and reference cells constant over time (3).
Most DNA oligonucleotides melt cooperatively meaning that the equilibrium
equation can be described as a two state process where the DNA goes from folded to
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“denatured” or unfolded (3). The melting temperature,Tm, represents the temperature
where the fraction of unfolded biomolecule equals the folded biomolecule (2, 3). When
ligand or small molecule is added to the DNA solution the Tm may increase due to
stabilization of the higher order structure(s) (2). The ΔTm can then be related to the
binding affinity for the interaction of the ligand with the DNA macromolecule. This
calculated ΔTm for the interaction of the ligand and the macromolecule can assist in
discovering and evaluating novel drug compounds (5, 8, 9).
Differential Scanning Calorimetry (DSC) experiments were performed using a
Microcal VP-DSC instrument (Microcal, Northampton, MA). The experimental scan rate
was set at 90°C/h with a temperature range anywhere from 10° up to 110° C. The
thermograms for all the oligonucleotides exhibited one or more independent “two-state”
melting transitions. The thermograms were deconvoluted using Origin 7.1 software into
the minimum number of “two-state” transitions needed to fit the thermogram within
expected experimental error. DSC data was analyzed based on a model assuming that
each “two-state” transition observed in each thermogram represents a unique structure or
folded conformation. Through Origin analysis, values for the melting temperature, Tm,
and the calorimetric ΔHcal, and Van’t Hoff enthalpies ΔHVH, for each transition observed
was reported (5). The calorimetric enthalpy, ΔHcal , is the calculated equivalent to the
area under the curve for each melting transition. The energy for the unfolding of the
DNA structure is calculated as an integration of the raw excess heat capacity shown in
the Figure 2.2 (3).
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∆H cal =

Tu

∫C

p

(ex)dT

T0
Figure 2.2

Equation for the determination of the calorimetric enthalpy, ΔHcal.
Isothermal Titration Calorimetry

The primary technique used to probe ligand interactions with the various Gquadruplex structures was isothermal titration calorimetry (ITC). A schematic of the
instrument as well as a typical data set for a 1:1 binding process are shown in (Figure
2.2). ITC is commonly used to determine thermodynamic parameters of biochemical
systems (2, 10). ITC instrumentation is used to monitor heat changes produced through
small molecule/ligand and macromolecule interactions. A typical ITC experiment
involves the injection of small volumes of a ligand of known concentration into a cell
filled with a dilute macromolecule solution of known concentration. Representation of a
typical ITC instrument is shown in Figure 2.3 depicting the, reference cell, sample cell,
syringe, and adiabatic shield (10). The sample cell in and ITC instrument is equipped
with a power source supplied to the reference and sample cells to maintain a 0
temperature difference between the two cells throughout the reaction. As a ligand is
titrated into the macromolecule sample either heat is given off or absorbed. The
difference in heat from the reaction with the ligand in an exothermic process results in
less power (heat) being supplied to the sample cell in order to keep the sample cell at a
constant temperature whereas an endothermic binding process results in more power
(heat) being supplied to the sample cell in order to keep the sample cell at a constant
temperature (10).
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cell, syringe, adiabatic shield and an example of output data: integrated
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The experimental data result in binding thermograms that can be modeled to
determine the binding constant, K, enthalpy changes, ΔH, entropy changes, ΔS, and the
saturation stoichiometry, n (10). By understanding the entropic and enthalpic
contributions to the free energy (ΔG), and the relative binding constants associated with
each binding event, a better understanding of ligand binding can be developed. The most
simple ligand/macromolecule interaction can be best described as one where a
macromolecule binds a single ligand, an example of the integrated heats of reaction for a
1:1 binding process are shown in Figure 2.2. In this example the binding constant is
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described as the ratio of the concentration of the bound complex, [ML], to that of the free
ligand, [L], and the concentration of the free macromolecule, [M] as described by the
equation in Figure 2.4 (10, 11).

Figure 2.4

Equation for the determination of the binding constant, K.

The equations describing the fraction of binding sites that have a ligand bound, θ,
is described in the equation shown in Figure 2.5. This Equation best describes that the
heat of binding the ligand to the macromolecule results from the change in, θ, the number
of moles of the macromolecule interacting, and the ΔH of the reaction.

Figure 2.5

Equation for the fraction of binding sites that have a ligand bound, θ.

The Gibbs free energy, ΔG°, can be expressed in terms of the enthalpy of
changes, ΔH, entropy changes, ΔS, and the absolute temperature in Kelvin as described
by the equation shown in Figure 2.6 (10, 11).

∆G° = ∆H° − T∆S°
Figure 2.6

Equation for the determination of the standard state Gibb’s free energy,
ΔG°.

This equation is useful however there are some additional variables that must be
considered when evaluating the interactions between ligands and macromolecules in
dilute aqueous solutions. One of the greatest influences in ligand binding to
macromolecules is the temperature dependence of ΔS and ΔH as a result of the
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hydrophobic effect (10, 11). The hydrophobic effect is best described as the interaction
between non-polar ligands with macromolecules in aqueous solution. In aqueous
solution the non- polar ligand interacts with the macromolecule in such a way that
reduces its interactions with the polar aqueous solutions, i.e. a non polar ligand being
sequestered in a hydrophobic binding site of a macromolecule. Because of these
hydrophobic ligand interactions a more detailed description of the Gibbs free energy is
required, seen in the equation described in Figure 2.7 (10, 11).

T
∆G = [∆H°R + ∆C p (T − TR )] − T ×  S°R + ∆C p ln 
TR 

Figure 2.7

Equation for a more complete expression of the Gibb’s free energy, ΔG,
including terms that account for the hydrophobic effect.

Isothermal Titration Calorimetry (ITC) experiments described in these studies
were performed using a Microcal VP-ITC (Microcal, Northampton, MA). All titrations
were performed by filling the ITC cell with ~1.5 mL of oligonucleotide solution
concentration ranging from ~25-50μM. The cell was overfilled by adding ~57-5μL or
27-10 μL injections of ligand. The ligand concentration ranges varied to obtain a ligand
concentration approximately twenty times greater than oligonucleotide. All titrations
were run at 25°C and at a single supporting electrolyte concentration of 130 mM [K+]
BPES. Three replicate titration experiments were typically performed with each
oligonucleotides studied. The ITC data were fit using an independent sites model with
either two or three sites required to fit the data within experimental error. The nonlinear
regression fitting was done using Mathematica 5.0 and algorithms developed in our lab.
The ITC fitting procedures used have been described previously (1, 5, 8, 10-13).
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Ultra-Violet-Visible Spectroscopy
UV-vis is a universal spectroscopic technique that measures the relative
absorbance vs. transmittance intensity of light passing through a given sample. The
absorbance, A, of solution is directly proportional to the path length, b, its molar
absorptivity constant for a given solution, ε, and the concentration, C, of the species
being absorbed as described by Beer’s law(A = ε × b× C) (6, 14).
The concentrations of all DNA and ligand solutions were verified using UV-vis
and the molar extinction coefficients determined by using a nearest-neighbor method for
single stranded DNA (1). UV-Vis titrations were performed using an Olis 8452A diode
array spectrophotometer (Olis, Bogart, GA). These titration experiments used DNA and
ligand solutions having nominal concentrations of 10μM in BPES buffer for both the
oligonucleotide and the porphyrin. Each titration experiment was performed in two parts
as described by Dettler et al (13). Absorbance spectra were collected from 200 to 600 nm
after each injection of either DNA into the porphyrin solution or the porphyrin into the
DNA solution. Using this procedure data were collected over the entire mole fraction
range in porphyrin to DNA from 0 to 1.0 with two overlapping points at the end of each
“half-titration.” The job plot was analyzed to determine the end points, or
stoichiometries, for the formation of the various porphyrin/DNA complex species (1517).
Circular Dichroism Spectroscopy
CD is a powerful technique that can be used to further characterize higher order
DNA structures, including G-quadruplex and i-motif, and evaluate the effects of
sequence, ligand binding, ionic strength and pH (18-21). There are limitations of CD
spectral analysis of G-quadruplex and i-Motif structures however there are some strong
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associations and observations that can be made between spectra for higher order DNA
structures (21). CD ultimately measures the difference in the absorption of right and lefthanded circularly polarized light depicted in Figure 2.8 (21). CD is highly sensitive to
minor differences in nucleic acids and biopolymers because of their asymmetric nature
(6). Minor changes in DNA structural conformations produce noticeable spectral results.
CD was used to monitor DNA conformation changes as well as verify concentrations at
various points through each of these studies.

Figure 2.8

Representative diagram of the incident beam, the left and right polarizing
components, and an example of the resulting CD spectra.

CD analysis was performed using an Olis DSM 20 CD Spectrophotometer (Olis,
Bogart, GA). Spectra were collected over a wavelength range of 200-500 nm equipped
with a 1 cm path length quartz cuvette. All CD measurements and titrations were
performed at 25oC in 130 mM [K+] BPES buffer at pH 7.0 with spectra collected over a
wavelength range of 200-500 nm. The DNA concentration was nominally 3-5µM in Gquadruplex and a titration involved the addition of the ligand to the DNA solution. CD
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spectra were collected at mole ratios (ligand:DNA) of 0.5:1, 1:1, 2:1, 3:1, 4:1, 5:1 and 6:1
Ligand/DNA for each of the oligonucleotides respectively.
Fluorescence Spectroscopy
When an electron of an atom or molecule is excited from its ground state to a
higher energy state, the resulting relaxation back to the ground state can either result in a
energy transferred as heat or the emission of a photon (6). The emission of a photon, or
Fluorescence, can be induced and measured using fluoresce spectroscopy. Using a
monochromator a wavelength of exciting light can be used to excite the sample and a
second monochromator can be used to scan various wavelengths to measure the emission,
producing a spectra for the excitation as well as the emission (6). The intensity of the
fluorescence emission can be useful in a number of biophysical experiments. We report
here the use of Fluorescence spectroscopy as a supporting method to evaluate the binding
of fluorescent ligands to higher order G-quadruplex DNA structures (9). From the
experimental results the saturation stoichiometry can be determined as well as the spectra
can provide structural insight related to the binding modes.
Fluorescence emission spectra were collected using a FluoroMax-3
spectrofluorimeter (Horiba Jobin Yvon, Edison, NJ) equipped with a 1 cm path length
quartz cuvette. The total concentration of the porphyrin was kept constant throughout the
titration (900µM TMPyP2, or TMPyP3, and 1200 µM TMPyP4) while the concentration
of the G-quadruplex DNA titrant increased from 0 to 300 µM over the course of the
experiment. The TMPyP2, TMPyP3 and TMPyP4 solutions were excited at 424 nm, 417
nm and 433 nm, respectively. Emission spectra were collected from 600 to 800 nm after
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each injection of DNA into the porphyrin solution. All fluorescence measurements and
titrations were performed at 25oC in KBPES buffer (pH 7.0).
Analytical Ultracentrifugation
Sedimentation velocity is an (AUC) method that measures the rate at which
molecules move in response to centrifugal force generated in a high speed centrifuge.
The species in solution are separated based upon shape, mass, and the size distribution
within the solution (6). From these sedimentation velocity experiments size and mass of
the DNA sequences in solution can be compared relative to known single stranded
(random coil) or higher ordered structure species. Sedimentation velocity experiments
were performed on a Beckman-Coulter Proteome Lab XL-A analytical ultracentrifuge.
Experiments were performed at 20 ºC with a rotor speed of 60,000 rpm. DNA
concentrations ranged from 0.82 to 3.4 μM. Typically 35 to 40 scans were collected for
each sample per experiment. Sedimentation velocity experiments were analyzed with
SEDFIT using a partial specific volume (0.56 cm3/g) calculated from the oligonucleotide
sequence as described by Hatters et al (22) .

For comparative purposes, the

sedimentation coefficient for a c-MYC 22-mer was calculated using HydroPro and the
available PDB file for the NMR determined quadruplex structure (23, 24).
Polyacrylamide Gel Electrophoresis
Polyacrylamide Gel Electrophoresis (PAGE) is a fast inexpensive technique that
is valuable in the separation of nucleic acids and provides information about the
structural diversity of a given sample. In non-Denaturing PAGE experiments, a uniform
external electric field is applied to a neutral gel containing samples of native nucleic acid
solutions (6). The electrophoretic mobility of a particle in the gel is proportional to the
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ratio of the velocity of a that dispersed particle, V, in an applied electric field, as seen in
the equation shown in Figure 2.9 (6).

Figure 2.9

The equation for the electrophoretic mobility of a particle,

The nucleic acid sequence/structures (particles) have an overall negative charge
from phosphodiester backbone of the DNA and migrate based upon the overall size of the
DNA. DNA molecules that are highly compact, i.e. folded/base paired, will migrate
through the gel faster than single stranded or larger complexed molecules because they
interact less with the gel matrix. Non-denaturing gel conditions are mild and allow for
the DNA to stay folded or complexed as it would be in dilute solution, therefore any
higher order structure remains intact as the particles migrate through the gel. Nucleic
acids of the same size will migrate to the same location in the gel. The resulting bands of
separated nucleic acids allow for the determination of the relative sizes of the
folded/unfolded species in solution (6). For example intermolecular G-quadruplex
structures are folded and more compact than single stranded or intramolecular folded
structures because they do not interact with or have their migration inhibited by the gel
matrix.
Gel electrophoresis experiments were performed using 20% non-denaturing
polyacrylamide gels obtained from Biorad. A 10 bp and 20 bp DNA step ladder was
obtained from Promega for molecular weight referencing and the DNA stained with
Stains-All ® (Sigma Aldrich) for visualization. All samples were prepared with the
standard 130 mM [K+] BPES pH 7.0 with 10% TBE buffer was used as the running
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buffer. All samples were prepared at nominally 100 µM and were annealed at 95 °C for
10 minutes then flash cooled in ice at ~4 °C for approximately 10 minutes before loading.
All PAGE experiments were run for approximately 45 minutes at 150 V. Gels were then
stained with EtBr and visualized using a UV-lamp.
DMS Footprinting
The purpose of DMS foot printing was used further characterize G-quadruplex
formation and to determine the specific guanines that are involved in G-tetrad formation
(25). The DNA sequences were radio labeled at their 5’ terminal ends with 32P radio
labeling and treated with DMS and piperidine solutions. The guanines that are involved
in Hoogsteen hydrogen bonding within the tetrad are protected from cleavage while the
guanines not involved in tetrad formation are methylated at their N7 and N3 positions.
The piperidine ultimately cleaves the methylated guanine bases the cleavage products are
then subjected to and separated with gel electrophoresis techniques (25, 26). A more
complete description of all the DMS footprinting methods and procedures is described in
supplemental material of Chapter 5.
Molecular Modeling
Throughout this dissertation molecular modeling techniques were used to
construct models of the Bcl-2 and K-ras G-quadruplexes. The WT K-ras model structures
were constructed using the molecular modeling software Discovery Studio (Accelrys,
San Diego, CA). The G-Quadruplex portion was obtained by starting with a 22-mer GQuadruplex NMR solution structure, obtained from the Protein Data Bank (pdb accession
code: 1xav)(27). The K-ras WT was best described as using a series of Guanine runs or
“segments”. The segments were assigned as the following: segment 1 contains G1, G2,
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and G3; segment 2 contains G5, G6, T7, and G8 with T7 is kinked out facilitating G8 in a
G-tetrad; segment 3 contains G10, G11, and G12; segment 4 contains G17, G18, and
G19; and segment 5 contains G24, G25, and G26.
Our five models of K-ras WT quadruplex contains four out of the above five
segments in a sequential order; namely they are 1234, 1235, 1245, 1345, and 2345. In
order to simplify the mutations we made to the PDB structure we will refer to the 1xav
sequence with an apostrophe ( ’ ) following the nucleotide name to indicate where we
made substitutions to mirror the K-ras G-quadruplexes. In the building of the WT
models, T1’, G2’, and A3’ of the 1xav structure were removed. For model 1234 and
1235, T7’ is mutated to Cytosine. To create the kink in segment 2 the phosphodiester
bond between G9’-G10’ was broken and a thymine was inserted, ligated with the 3’
hydroxyl group of the G9’, and ligated with the 5’ phosphate group of the G10’in the
proximal space. A12’ was also deleted then the 3’ hydroxyl group of T11’ is then
ligated with the 5’ phosphate group of G13’. To connect segment three with either
segment four or five, T16’ was deleted and replaced with the correct sequence using the
method described above. This same procedure was applied to create model 1245, 1345,
and 2345.
The mutant K-ras model structures were constructed in a similar manner to the
WT structures using the Discovery Studio software (Accelrys, San Diego, CA). These 14
K-ras mutants either form parallel quadruplex or mixed parallel/anti-parallel
quadruplexes (as determined by CD experiments.) The procedure for the base
substitutions and deletions were the same as those described for the WT. In order to
create a mix parallel/anti-parallel G-quadruplex structure the bonds connecting the three
guanines subsequent to the second lateral loop were broken. The sugar and phosphate
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portions of each of the three guanines were rotated 180˚ while leaving the bases unrotated so that the three guanines sequence has opposite direction of what it used to be.
The nucleotides in all other positions are then replaced by the specified sequence and
then ligated if necessary using the same method described earlier.
All the initial WT and Mutant structures were typed with CHARMm forcefield
and Momany-Rone partial charge. Minimization of the initial structures was performed
using the 1,000 cycles Smart Minimizer algorithm using Generalized Born implicit
solvent model and with all atoms in the three G-tetrads constrained. Each Smart
Minimizer cycle contains 1,000 steps of Steepest Descent followed by Conjugate
Gradient minimization. The initial minimized structures were then solvated using the
Explicit Periodic Boundary solvation model which creates an orthorhombic solvent cell
around the structure. The dimension of the cell is dependent upon the size of the
structure. However, the minimum thickness of the solvent is set at 7.0 Å. Inside this
solvent cell, potassium and chloride ions were added to a concentration of 145 mM. The
resulting number of water molecules in each structure ranges from under 3,000 to 5,500.
The solvated molecule then underwent 4,000 minimization cycles using the similar Smart
Minimizer parameters. Conformational energy is calculated for the minimized structures.
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CHAPTER III
A CASE FOR G-QUADRUPLEX INTERCALATION: BCL-2 PROMOTER
SEQUENCE INTERACTIONS WITH THE CATIONIC PORPHYRINS,
TMPYP2, TMPYP3, AND TMPYP4
Abstract
The interactions of three related cationic porphyrins, TMPyP2, TMPyP3 and
TMPyP4 with four Bcl-2 promoter sequence G-quadruplexes were studied using
Isothermal Titration Calorimetry, Circular Dichroism, Fluorescence, and UV-Vis
spectroscopy. TMPyP4, (5, 10, 15, 20–meso-tetra (N-methyl-4-pyridyl) porphyrin), is
shown to bind to all of the Bcl-2 model G-quadruplexes by two different binding modes,
an end binding mode and a weaker mode resembling intercalation. Saturation
stoichiometry for all of the TMPyP4/Bcl-2 promoter sequence quadruplexes is 4:1, with
the bound TMPyP4 exhibiting both significant absorbance hypochromicity and a red shift
in the soret band that is consistent with a planar stacking interaction. The related ligands
TMPyP2 and TMPyP3 are shown to bind to all four Bcl-2 model G-quadruplexes by a
single end binding mode with a saturation stoichiometry of 2:1. The non-planar shape of
the TMPyP2 and TMPyP3 molecules, in which the pyridinium rings are forced out of
plane relative to the porphyrin ring, results in reduced affinity for the mode 1 end binding
interaction and elimination of intercalation binding. The highest affinity mode for
binding the three cationic porphyrin ligands to each of the Bcl-2 promoter sequence
quadruplexes follows the general trend: TMPyP4 >TMPyP3 >> TMPyP2.
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Introduction
The promoter region of the B-cell lymphoma-2 (Bcl-2) gene is guanine and
cytosine rich (1-3). Bcl-2 expression at low levels is required for cell survival, however,
upregulation of the Bcl-2 gene can lead to formation of many common cancers and has
been reported to play a role in resistance to conventional cancer treatments (2-4). A 39
base pair region, located from19 to 58 base pairs upstream of the Bcl-2 P1 promoter,
plays a crucial role in the regulation of Bcl-2 transcription (5). Dai et al used NMR and
CD methods to demonstrate that the Bcl-2 39-mer purine rich strand folds into multiple
intramolecular G-quadruplex structures (6).
G-quadruplex structures are thought to be generally involved gene regulation,
with G-rich sequences found upstream from as many as 40% of all human genes (7).
Small molecules, which specifically interact with quadruplex DNA have been shown to
act as selective inhibitors of telomerase thereby demonstrating some potential as anticancer therapeutics (8-11). Cationic porphyrins are known to associate with Gquadruplex DNA. Proposed binding modes include: groove binding (with or without
self-stacking along the DNA surface), end- stacking, and intercalation (12-15). The
exact nature of the interactions between cationic porphyrins and G-quadruplex DNA
depends on the folding topology and base sequence of the G-quadruplex and on the
molecular structure of the porphyrin (16).
Haq et al demonstrated that the saturation stoichiometry for porphyrin binding to
G-quadruplex DNA depends on the number, n, of stacked G-tetrads and the formula
(n+1) (13). The Lewis group reported that the binding stoichiometry of the cationic
porphyrin (5, 10, 15, 20–meso-tetra (N-methyl- 4-pyridyl) porphyrin), TMPyP4, to the c43

MYC and Bcl-2 promoter region G-quadruplexes is 4:1 at saturation (17-19). Their
microcalorimetric and spectroscopic results were consistent with two TMPyP4 binding
modes for both the c-MYC and Bcl-2 promoter quadruplexes; external or end binding
and intercalation (17-19). Wei et al has similarly suggested that TMPyP4 binds to Gquadruplex DNA by a combination of binding modes that include external (end) stacking
within the loop region and intercalation between G-tetrads with complex binding ratios of
both 2:1 and 4:1 between TMPyP4 and G-quadruplex DNA (20). In addition, Kumar et
al has reported that the concentration of porphyrin increases the relative concentration of
quadruplex DNA in equilibrium with duplex DNA in dilute solutions (21).
The majority of previous studies have focused on the planar cationic porphyrin
TMPyP4, however, Han et al has described the interactions between the related ligands
(5, 10, 15, 20–meso-tetra (N-methyl- 2-pyridyl) porphyrin), TMPyP2, and (5, 10, 15, 20–
meso-tetra (N-methyl- 3-pyridyl) porphyrin), TMPyP3, with G-quadruplex forming
oligonucleotides using gel mobility shift and helicase assays (22). The structures of the
three cationic porphyrins differ only in the location of the bulky N+-CH3 substituent
group in the pyridinium rings. Steric hindrances force the four substituent pyridinium
rings in the TMPyP2 and TMPyP3 molecules to be out of plane relative to the porphyrin
ring. In the present study, we looked at the interaction of three cationic porphyrins
(TMPyP2, TMPyP3, and TMPyP4) with G-quadruplex forming sequences from the Bcl-2
promoter region. The results of this study provide new insight into the origin of
porphyrin/G-quadruplex DNA interactions, including the influence of ligand geometry
and the influence of the intramolecular DNA folding topology on the thermodynamics for
these interactions
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Materials and Methods
The four Bcl-2 WT oligonucleotide sequences used in this study were obtained
from Oligos Etc (Wilsonville, OR). The sequences, shown in were chosen to include all
combinations containing four or more sequential runs of three or more guanines within
the native sequence.
Table 3.1
Oligo

Bcl-2 Model P1 Promoter Polypurine Oligonucleotide Sequences.
1-5

6-9

10-26

27-32

33-39

39Bcl-2 AGGGG CGGG CGCGGGAGGAAGGGGGC GGGAGC GGGGCTG
30Bcl-2
27Bcl-2

CGCGGGAGGAAGGGGGC GGGAGC GGGGCTG
CGGG CGCGGGAGGAAGGGGGC GGGAGC

26Bcl-2 AGGGG CGGG CGCGGGAGGAAGGGGGC

Bcl-2 stock solutions were prepared by dissolution of weighed amounts of
lyophilized oligonucleotide into [K+] BPES buffer with a salt concentration of 130 mM
[K+] and a pH of 7.0 (17). Approximately 1 mL of the oligonucleotide was exhaustively
dialyzed (1000 molecular-weight cutoff membrane) with two changes of buffer solution
(1 L, 24h each) at 4°C. The concentrations of all DNA solutions were verified using
ultraviolet-visible spectrophotometry (UV-Vis). Molar extinction coefficients were
determined for each of the four oligonucleotides using a nearest-neighbor method for
single stranded DNA (17, 23). The extinction coefficients at 260 nm were: 3.090×105 M1

Cm-1 (39Bcl2), 1.965×105 M-1Cm-1 (26Bcl2), 2.078×105 M-1Cm-1 (27Bcl2), and

2.304×105 M-1 Cm-1 (30Bcl2).
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TMPyP2, TMPyP3, and TMPyP4 were obtained from Frontier Scientific (Logan,
UT). All cationic porphyrin solutions were prepared by dissolution of a known amount
of porphyrin into a measured volume of the dialysate buffer solution. The porphyrin
solution concentrations were determined from UV-Vis absorbance measurements in the
414-424 nm region and the following molar extinction coefficients: TMPyP4, ε424=2.26 ×
105 M-1cm-1; TMPyP3, ε417=2.5× 105 M-1cm-1; and TMPyP2, ε414=1.82 × 105 M-1cm-1
(13).
Results
The interactions between the three cationic porphyrins (TMPyP2, TMPyP3, and
TMPyP4) and model Bcl-2 promoter sequence G-quadruplex motifs were probed using
CD spectroscopy. The CD spectra for the 39-mer Bcl-2 promoter sequence quadruplex
in the presence of saturating amounts TMPyP2, TMPyP3, and TMPyP4 are shown in
Figure 3.1.

Figure 3.1

CD spectra for complex of the 39Bcl-2 P1 promoter G-quadruplex
saturated with bound TMPyP4, TMPyP3, or TMPyP2. The inset shows an
expanded view of the CD spectra in the range of the porphyrin absorption
spectrum. The very small negative CD signals in the 400-450 nm range are
only observed in the presence of excess porphyrin for TMPyP4 and
TMPyP3.
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The Bcl-2 39-mer porphyrin free spectrum is typical for a G-quadruplex structure
with a predominantly parallel folding topology. Parallel G-quadruplex motifs typically
exhibit a positive CD band near 264 nm and a negative CD band near 240 nm (1, 6, 30).
The small shoulder at 295 nm is an indication of minor species with anti-parallel folding
topology in the 39Bcl-2 quadruplex mixture. Although the data are not shown, the CD
spectra for the shorter Bcl-2 sequences studied here (30Bcl-2, 27Bcl-2, and 26Bcl-2) are
similar to the CD spectrum for the 39-mer shown in Figure 3.1. The free cationic
porphyrins do not possess a CD signal and porphyrin ligands bound to the G-quadruplex
do not exhibit a significant induced CD signal. The obvious point to be made, is that
whether the porphyrin is self-stacking, stacked on the terminal G-tetrads in the
quadruplex structure, or intercalated between G-tetrads in the quadruplex, the porphyrin
environment in the complex is not asymmetric. The CD spectra for the 39-mer Bcl-2
promoter sequence quadruplex is unchanged by the addition of saturating amounts of
TMPyP2, TMPyP3, or TMPyP4 either in CD band intensity or in CD band wavelength.
The very low intensity negative bands in the 425 nm region (shown in the inset in Figure
3.1) are the likely result of very weakly bound porphyrin sitting in the quadruplex
grooves. This effect is only seen at porphyrin concentrations exceeding the binding
capacity for the higher affinity sites on the G-quadruplex and is only observed at very
high porphyrin concentrations where porphyrin aggregation is beginning to occur.
The interactions between the three cationic porphyrins and model Bcl-2 promoter
sequence G-quadruplex motifs were also probed using fluorescence techniques.
Emission spectra for the porphyrin ligands were recorded in DNA free solutions and in
the presence of varying amounts of Bcl-2 promoter sequence quadruplex DNA. The
fluorescence emission spectra observed for TMPyP4 in a G-quadruplex DNA free
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solution and in solutions containing either 2 moles of TMPyP4/mole of DNA or 4 moles
of TMPyP4/mole of DNA are shown in Figure 2.

Figure 3.2

Fluorescence emission spectra obtained for the TMPyP4 in the presence or
absence of 39Bcl-2 G-quadruplex DNA. Spectrum 1 labeled TMPyP4 is for
the free porphyrin (in the absence of DNA). Spectrum 2 is for TMPyP4 in
the (TMPyP4)2 • 39Bcl-2 complex. Spectrum 3 is for TMPyP4 in the
(TMPyP4)4 • 39Bcl-2 complex.

In dilute solution, each of the three porphyrins exhibit complex emission spectra.
TMPyP2 exhibits an emission spectrum with emission maxima at 640, 660, and 705 nm,
while TMPyP3 exhibits emission maxima at 660 and 705 nm, and TMPyP4 exhibits
emission maxima at 660 and in the range of 720 to 730 nm. In all instances, the total
fluorescence emission is quenched in the presence of quadruplex DNA. This is a clear
indication of porphyrin binding to G-quadruplex DNA. It is obvious, from the
fluorescence spectra shown in Figure 3.2, that TMPyP4 fluorescence is changed on
formation of the TMPyP4/39Bcl-2 complex. At low mole ratios of TMPyP4 to DNA
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(e.g. ratio ≤ 2.0), the TMPyP4 fluorescence is attenuated across the entire wavelength
range of 625 to 775 nm. At higher mole ratios (e.g. TMPyP4/DNA ≈ 4:1), the TMPyP4
fluorescence emission spectrum changes dramatically, exhibiting a significant increase in
fluorescence in the 660 nm region, a nonlinear attenuation near 700 nm, and a red shift in
the λmax for the 730 nm peak in the emission spectrum. Although in essence we are only
showing two points in a DNA titration of TMPyP4 (Figure 3.2), the spectra shown
represent the end points for formation of the 2:1 complex (with only end binding) and for
the formation of the 4:1 complex with two different binding modes evident.
The fluorescence spectra for the interaction of TMPyP4 with the (30Bcl-2, 27Bcl2, and 26Bcl-2) quadruplexes were similar to those shown in Figure 3.2 for the longer 39mer oligonucleotide. Changes in the emission spectra for TMPyP2 and TMPyP3 (data
not shown) are linear with increasing DNA up to the point of saturation (2:1) porphyrin
to DNA. The TMPyP2 and TMPyP3 fluorescence is quenched proportionally over the
emission wavelength range (600 to 800 nm) by the DNA interaction. These results are
consistent with TMPyP4 having a higher affinity for G-quadruplex DNA than either
TMPyP2 or TMPyP3. They are also consistent with bound TMPyP4 occupying two
different environments in the saturated (4:1) TMPyP4/Bcl-2 promoter sequence
quadruplexes while bound TMPyP2 and TMPyP3 appear to occupy a single environment
in the saturated (2:1) complexes. The fluorescence experiments reported here for the
interactions of all three porphyrin ligands with the four different Bcl-2 promoter
sequences agree in general with the CD, UV-vis and ITC results reported previously for
interaction of TMPyP4 with c-MYC promoter sequence quadruplexes (17, 19, 31). As
expected, the interactions observed for each of the three porphyrins with the four model
Bcl-2 promoter were very similar.
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UV-vis absorption spectra were recorded for TMPyP2, TMPyP3 and TMPyP4 in
dilute solution, in both the absence and the presence of added DNA. Changes in the
porphyrin absorption spectra as a function of added DNA were analyzed to determine
porphyrin binding stoichiometry and porphyrin binding environment. The UV-vis
titration results were identical whether the 39-mer sequence or shorter Bcl-2 promoter
sequences were used. In the case of TMPyP4, the λmax for the porphyrin soret band
shifted from 423 nm for the free ligand to 441 nm for the ligand in the saturated (4:1)
complex (an 18 nm red shift) and an isobestic point was observed at 436 nm in the DNA
titrations. In the case of TMPyP3, the λmax for the porphyrin soret band shifts from 417
nm to 431 nm (a 14 nm red shift) and an isobestic point is observed at around 426 nm. In
the case of TMPyP2, the λmax for the porphyrin soret band does not show a significant
shift from 414 nm as observed for the free ligand. The hypochromicity for the porphyrin
soret band absorbance in each G-quadruplex complex was calculated by following the
procedure described by Keating et al (27). The percent hypochromicity in the porphyrin
absorbance was well correlated with the apparent ligand affinity for the model Bcl-2
quadruplexes: TMPyP4> TMPyP3>> TMPyP2.
The method of continuous variation analysis (Job plot) was used to determine the
number of molecules of porphyrin binding to G-quadruplex DNA at saturation (32).
Figure 3.3 shows the Job plots obtained for the interactions of TMPyP2, TMPyP3, and
TMPyP4 with 39 Bcl-2 quadruplex DNA. Differences in the absorption maxima of the
soret band were used to generate the job plots. Binding stoichiometries of three porphyrin
drugs (TMPyP2, TMPyP3 and TMPyP4) interacting with the four different Bcl-2 Gquadruplex DNA were determined to be 2:1 for TMPyP2 and TMPyP3 and 4:1 for
TMPyP4. As seen in Figure 3.3, the intersections of the lines appear at mole fractions of
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either 0.66 (2:1) or 0.8 (4:1). The data are consistent with data previously published for
the interaction of TMPyP4 with c-MYC and Bcl-2 promoter sequence quadruplexes (17,
33).

Figure 3.3

Composite Job plot generated from the Uv-vis titration obtained for the
39Bcl-2 promoter sequence. The open triangles (Δ) and the (×) correspond
to data for the titration of the 39Bcl-2 with TMPyP2. The asterisks (*) open
circles (○) correspond to data for the titration of the 39Bcl-2 with TMPyP3.
The open diamonds (◊) and the open square (□) correspond to data for the
titration of the 39Bcl-2 with TMPyP4. Each titration was completed in two
parts to cover the entire mole fraction range. Data at low mole fractions
were for the addition of porphyrin into DNA solutions while the data at
high mole fractions were for the addition of DNA into porphyrin solutions.

Typical ITC data obtained for the titration of the 39Bcl-2 G-quadruplex DNA
with TMPyP2, TMPyP3, or TMPyP4 at 25OC in 100 mM KBPES (pH 7.0) buffer are
shown in Figure 3.4. The data points shown in each of the three representative
thermograms are the corrected integrated heat produced per injection, plotted with respect
to the mole ratio of porphyrin/DNA at each point in the titration.
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Figure 3.4

Typical ITC titration data (points) and nonlinear regression fits (solid lines)
are shown for three titration experiments in which a dilute solution of
porphyrin was added to a dilute solution of the annealed oligonucleotide in
the calorimeter cell. The upper panel represents data for the titration of
39Bcl-2 with TMPyP2 (Note the Y-axis is scaled from 0 to .3 kcals/mol).
The lower panel represents data for the titration of 39Bcl-2 with TMPyP3
and TMPyP4. The best fit parameters for the non linear regression analysis
of these ITC data are given in Table 3.1.

It needs to be noted that since the TMPyP2 affinity and enthalpy change are much
smaller than for the other porphyrins, the TMPyP2 data in Figure 3.4 are shown on a
magnified (10X) scale. After making corrections for blank heat effects and titrant
dilution, the corrected heat data were fit to a thermodynamic model using a non-linear
regression algorithm to obtain best fit values for the equilibrium constant(s), Ki, enthalpy
change(s), ∆Hi, and reaction stoichiometry, n, for complex formation. The TMPyP2 and
TMPyP3 thermograms were fit with a model having a single binding mode, with two
equivalent binding sites per DNA, and a saturation stoichiometry of 2:1. The TMPyP4
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thermograms required a more complicated model having two binding modes, with each
binding mode having two equivalent sites, and a saturation stoichiometry of 4:1. The best
fit values of the thermodynamic parameters estimated for the cationic porphyrin
interactions with the 39Bcl2 G-quadruplex DNA are listed in Table 3.2. .
Table 3.2

ITC Derived Thermodynamic Parameters for the binding of porphyrin
ligands (TMPyP2, TMPyP3, and TMPyP4) to the 39Bcl-2 promoter
sequence G-Quadruplex.

Ligand K1 (M-1)
×10-7

ΔG1

ΔH1

-TΔS1

(kcal/mol) (kcal/mol) (kcal/mol)

K2 (M-1)
×10-5

ΔG2

ΔH2

-TΔS2

(kcal/mol) (kcal/mol) (kcal/mol)

TMPyP2

0.007

-6.61

-0.62

-5.99

-

-

-

-

TMPyP3

0.026

-7.37

-4.11

-3.27

-

-

-

-

TMPyP4

0.37

-8.96

-4.24

-4.72

0.85

-6.73

-9.87

-3.14

TMPyP4+

4.2

-10.4

-1.8

-8.6

3.6

-7.6

-6.1

-1.5

TMPyP4*

0.10

-8.2

-4.6

-3.6

1.3

-7.0

-12.3

+5.3

TMPyP4#

1.1

-9.6

-4.5

-5.2

1.7

-7.1

-6.7

-0.4

+

These data are for the interaction of TMPyP4 with the WT 27mer Bcl-G-quadruplex
(19)
*

These data are for the interaction of TMPyP4 with the Bcl-2 3:7:1 mutant 23mer Gquadruplex (19).
#

These data are for the interaction of TMPyP4 with the Bcl-2 3:5:3 mutant 23mer Gquadruplex (19)
Parameter values listed for the interactions of TMPyP4 with the 39Bcl-2 promoter
sequence G-quadruplex are very similar to the Ki, ΔGi, ΔHi, and –TΔSi values reported

previously for the interaction of TMPyP4 with the c-MYC promoter G-quadruplex (17,
31)
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Discussion
The 39Bcl-2 oligonucleotide used in this study contains six continuous stretches
of guanines with one stretch of five guanines, two stretches of four guanines and three
stretches of three guanines each. The Hurley group has reported that the 39Bcl-2 P1
promoter sequence forms a mixture of three distinct intramolecular G-quadruplex
structures in the presence of K+ ions (1, 6). Numerous others have shown that cationic
porphyrins can bind to G-quadruplex DNA and stabilize the DNA structure through π-π
stacking interactions between the aromatic porphyrin core and a G-tetrad or through
electrostatic interactions between positively charged nitrogen atoms of the pyridyl rings
and negatively charged phosphate oxygen atoms of DNA (1, 13, 14, 22, 34-36).
The CD results for the four Bcl-2 sequences used in this study agree with
previously published data obtained for Bcl-2 and c-MYC promoter sequence
quadruplexes (17, 19, 31). Specifically, each of the four Bcl-2 promoter sequence Gquadruplexes used in this study are best described as predominantly parallel structures
(exhibiting a large positive molar ellipticity in the 260 nm region) with a smaller
percentage of anti-parallel character (indicated by a small shoulder in the 295 nm region).
In addition, the CD spectra for each of the promoter quadruplexes is unchanged by the
addition of the three porphyrin ligands up to saturation (2:1 for TMPyP2 or TMPyP3, and
4:1 for TMPyP4) and there is little or no evidence of an induced CD signal for the bound
porphyrin (See Figure 3.1). Even though, previously published DSC data on the Bcl-2
(19) and c-MYC (17) promoter sequence quadruplexes show increased stability for the
TMPyP4 complexes over the free G-quadruplexes, it is clear that the bound porphyrin,
either end-stacked or intercalated, has almost no effect on the CD spectra for the G-
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quadruplex structure or on the equilibrium existing for the ensemble of G-quadruplex
folded conformers .
Summarizing the results of our UV-vis spectroscopy experiments, the porphyrin
soret absorbance band exhibits a red shift of approximately 18 nm for TMPYP4, 14 nm
for TMPyP3, and is not shifted in the case of TMPyP2. Attenuation of the porphyrin
absorbance on binding also exhibits a regular trend in that the average percent
hypochromicity for TMPyP4, TMPyP3 and TMPyP2 bound to four different Gquadruplex DNA’s is approximately 62 %, 47 % and 23 % respectively. It is generally
thought that a high degree of hypochromicity, e.g. >50%, in the soret band is indicative
of intercalation (20). The saturation stoichiometry for binding the three porphyrin
ligands to the four Bcl-2 promoter sequence quadruplexes was determined in UV-vis
titrations employing the method of continuous variation analysis (Job plots, Figure 3.3
(17, 32). The titration experiments done with TMPyP4 demonstrate two endpoints in the
Job plot, the first at a mole ration of 2:1, and the second at a mole ration of 4:1. This
result was similar to the stoichiometry previously reported for TMPyP4 complexes of cMYC NHE III1 promoter quadruplexes and was independent of the Bcl-2 sequence length
(17, 31). The titration experiments done with the TMPyP3 and TMPyP2 ligands only
showed a single endpoint at a mole ratio of 2:1, porphyrin to DNA. As stated earlier, our
interpretation of the stoichiometric data is that the non-planar TMPyP3 and TMPyP4
ligands can only participate in the exterior binding mode, presumably end stacking.
The TMPyP2, TMPyP3, and TMPyP4 total fluorescence is attenuated on binding
to Bcl-2 G-promoter sequence quadruplexes. The attenuation of the porphyrin
fluorescence on binding exhibits a regular trend in that the percent fluorescence
hypochromicity is largest for TMPyP3, followed by TMPyP4, and then TMPyP2.
55

Porphyrin bound to 39Bcl-2 exhibits hypochromicity in total fluorescence of 53%, 29%
and 13% for TMPyP3, TMPyP4, and TMPyP2 respectively at saturation (either 2:1 for
TMPyP2 and TMPyP3 or 4:1 for TMPyP4). For the two porphyrins (TMPyP3 and
TMPyP4), attenuation of total fluorescence decreases with the length of the
oligonucleotide, e.g the percent hypochromicity decreases from 53% to 32% in
comparing (TMPyP3)2•39BCcl-2 to (TMPyP3)2•26BCcl-2 and from 29% to 17% in
comparing (TMPyP4)2•39BCcl-2 to (TMPyP4)2•26BCcl-2. In contrast, TMPyP2
exhibits 13% hypochromicity in total fluorescence on binding to any of the four different
Bcl-2 promoter sequence quadruplexes. Whereas TMPyP2 and TMPyP3 exhibit
attenuation of their emission spectra over the wavelength range of from 600 to 800 nm
when bound to quadruplex DNA, TMPyP4 fluorescence changes in a more complex
manner on binding to the Bcl-2 quadruplexes. At low mole ratios, < 2:1, TMPyP4
emission is attenuated similarly over the entire wavelength of from 600 to 800 nm.
However, as the mole ratio of ligand to DNA increases from between 2:1 and 4:1,
TMPyP4 emission begins to increase in the wavelength region from 600 to 700 nm while
continuing to decrease in the wavelength region of from 700 to 800 nm. The decrease in
fluorescence intensity for either TMPyP2 or TMPyP3, and for TMPyP4 at mole ratios of
less than 2:1 is due to binding of the porphyrin externally or to the end of the G-tetrad
core structure. The externally bound porphyrin remains exposed to solvent and its
fluorescence is quenched by water surrounding the externally bound ligand. The increase
in the TMPyP4 fluorescence emission intensity, at mole ratios between 2:1 and 4:1
ligand/DNA, results from TMPyP4 intercalating between two G-tetrads in the quadruplex
DNA structure. The increase in emission intensity is due to energy transfer between the
intercalated porphyrin and the eight guanines located in the two G-tetrads stacked on the
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TMPyP4. The same argument can be used to explain the apparent lower hypochromicity
of bound TMPyP4 in comparison to bound TMPyP3 at low mole ratios (< 2:1). In effect,
the increase in fluorescence emission for even a small amount of intercalated TMPyP4 (at
low mole ratios) partially compensates for the attenuation of the externally bound
TMPyP4 resulting in TMPyP4 exhibiting decreased hypochromicity in comparison to
TMPyP3.
The ITC results present a consistent picture regarding the binding of the three
porphyrin ligands to the WT 39Bcl-2 promoter sequence quadruplex. We had previously
reported on the site and mode of TMPyP4 interactions with the WT 27Bcl-2 quadruplex
and two mutant 27nt sequences designed to fold into 3:7:1 and 3:5:3 loop isomer
quadruplexes (19). In this previous work, we found that both mutant sequence
quadruplexes exhibited lower affinity for TMPyP4 than the WT sequence and that the
isomer with the largest (7 Base) unstructured loop showed an approximate 40-fold
decrease in TMPyP4 binding affinity. The energetic profile reported here for the
interaction of TMPyP4 with 39Bcl-2 is similar to the energetic profiles reported
previously for TMPyP4 binding to the WT Bcl-2 27mer, Bcl-2 (3:7:1) 23-mer loop
isomer, and the Bcl-2 3:5:3 23mer loop isomer G-quadruplexes (19) (See Table 1). All
of these quadruplex motifs exhibit two binding modes for TMPyP4 and a saturation
stoichiometry of 4:1. The higher affinity mode combines an enthalpy contribution (-1.8
to -4.6 kcal/mol) with a more significant favorable entropy contribution of -4 to -9
kcal/mole in terms of (-TΔS). The lower affinity mode combines a more significant
enthalpy contribution (-6 to -12 kcal/mol) with a smaller entropy term ranging from -3 to
+5 kcal/mol. The energetic profiles reported here for the interactions of TMPyP3 and
TMPyp2 exhibit only one binding mode that is similar to the higher affinity TMPyP4
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binding mode, at least in terms of the relative entropy and enthalpy contributions to the
overall binding free energy change. Mode 1 binding affinity of the non-planar porphyrin
molecules is reduced by a factor of 10 for TMPyP3 and more than 60 for TMPyP2 in
comparison to TMPyP4 external binding or end-stacking. Neither TMPyP2 nor TMPyP3
show Mode 2 binding, presumably the result of the non-planar molecules inability to
intercalate.
We speculate here that the entropy driven energetics for Mode 1 binding, typical
for the binding of a hydrophobic ligand to the exterior of duplex DNA, can be used as a
model for the exterior or end binding interactions of the TMPyP4, TMPyP3, and
TMPyP2 ligands to the top or bottom of the G-quadruplex structure. The relative mode 1
affinities, TMPyP4 > TMPyP3 >> TMPyP2 are the result of the non-planar TMPyP3 and
TMPyP2 molecules being unable to stack flat on the terminal G-tetrads.

The energetic

profile for the second TMPyP4 binding mode is best described as an enthalpy driven
process. In the case of the insertion of planar aromatic ligands between the stacked bases
in duplex DNA, the typical exothermic enthalpy change is largely the result of increased
π-π stacking interactions between the DNA bases and the intercalated aromatic ligand
(37-41). We speculate here that the enthalpy driven energetics for Mode 2 binding,
typical for the intercalation of a planar aromatic ligand into duplex DNA, can be used as
a model for the stacking of the TMPyP4 ligand between two G-tetrads in the Gquadruplex structure. One subtle difference would be that in duplex intercalation there
are additional consequences of intercalation, i.e. some unwinding of the DNA duplex.
Although the intercalation binding mode remains hypothetical, there continue to
be reports that intercalation of planar ligands, like TMPyP4, can occur into G-quadruplex
DNA structures (27, 42-45). Wei et al reported a change in the G-quadruplex DNA
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conformation on intercalation of TMPyP4 using spectroscopic methods (20). Scheidt et
al has shown that the four 4-N-methyl pyridinium rings of the free TMPyP4 ligand are
nearly perpendicular to the plane of porphyrin core (46). The interactions of TMPyP4
with G-quadruplex DNA are stabilized by rotation of the pyridinium rings to attain a
planar geometry favoring both end stacking and/or intercalation. Therefore, intercalation
of the TMPyP4 ligand between G-tetrads must require moving two stacked G-tetrads
away from each other resulting in the small change in G-quadruplex structure observed
by Wei (47).
Gavathiotis et al reported an NMR structure (PDB 1NZM) having a spacing of 6.9
Å between a G- tetrad and a plane of four Adenines in a parallel stranded DNA
quadruplex d(TTAGGGT)4 containing the human telomere repeat sequence and
intercalated quinoacridinium ligands (42). Keating and Szalai reported EPR data
consistent with the intercalation of CuTMPyP4 into a d(T4G8T4)4 G-quadruplex (27).
Hounsou et al reported an NMR structure (PDB 2JWQ) having a spacing of 5.8 Å
between a G- tetrad and a plane of four adenines, with quinacridine based ligands
(MMQs) intercalated between two G and A planes (43). Cavallari et al have reported on
an MD simulation study in which they found that TMPyP can stack with G-tetrads in the
absence of interplane cations (45). They report TMPyP G-tetrad stacking distances of
4.3-4.7 Å and that TMPyP intercalation depends on the length of the quadruplex, the
stoichiometric ratio, and the edge termination motif. Although none of these previous
reports directly demonstrate TMPyP4 intercalation between G-tetrads in an
intramolecular G-quadruplex, we believe that intercalation cannot be excluded at this
time. The molecular modeling studies shown here for the interaction of TMPyP4 with
the 39Bcl-2 quadruplex (See Supporting Materials) demonstrate the possible intercalation
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of a planar TMPyP4 molecule in the Bcl-2 quadruplex, with the thickness of the
intercalation cavity (G-tetrad spacing) being approximately 7.0 Å. These latest molecular
modeling studies also reveal that for the non-planar TMPyP2 molecule to intercalate into
the Bcl-2 quadruplex, the inter-tetrad spacing would need to be enlarged to at least 9.0 Å
at a significant cost in energy. Our previous modeling paper demonstrated the possibility
of a saturated c-MYC TMPyP4/G-quadruplex having two end stacked ligands and two
intercalated ligands (18). In this case the separation of the internal G-Tetrads was 6.2 Å,
large enough to accommodate the planar TMPyP4 ligand without a significant increase in
tetrad spacing from the naked G-quadruplex (18).
The results of the spectroscopic and microcalorimetric experiments described
here, clearly demonstrate that the planar cationic porphyrin, TMPyP4, binds with high
affinity to Bcl-2 promoter sequence G-quadruplexes by two distinctly different binding
modes. We speculate that the two binding modes are an external or end stacking mode
and an intercalation mode. The intercalation mode is eliminated when the bulky N+-CH3
pyridinium substituent groups (in TMPyP2 and TMPyP3) force the ligand to become
non-planar, requiring a greater G-tetrad spacing for intercalation to occur (See Supporting
Materials.). Fluorescence emission spectra can only be explained by the placement of the
four bound TMPyP4 ligands in two completely different chemical environments in the
saturated complex. The non-planar structure of the TMPyP2 and TMPyP3 ligands results
not only in the loss of mode 2 binding but also in decreased affinity for the end binding
interaction. The TMPyP2 ligand can only weakly stack on the terminal G-tetrads, while
the TMPyP3 molecule can apparently at least partially rotate the pyridinium rings out of
the way to gain a better π-π overlap between the aromatic porphyrin core and the terminal
G-tetrads. The favorable binding interaction, that is inevitably lost in both the TMPyP2
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and TMPyP3 quadruplex interactions, is any loop or terminal base sequence overlap with
the end stacked ligand. The significance of this study is that it may be possible to design
drug molecules that specifically target either the end-stacking sites or specific features of
the G-quadruplex motif exterior (i.e. lateral loops). The bottom line is that if our binding
model is correct, there would be a number of unique opportunities for the future
development of G-quadruplex structure selective drugs.
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CHAPTER IV
K-RAS ONCOGENE PROMOTER REGION G-QUADRUPLEXES: POTENTIAL
DRUG TARGETS FOR THE TREATMENT OF PANCREATIC CANCER
Abstract
Expression of the K-ras proto-oncogene is a well known hallmark of pancreatic
cancer. We report here the results of a biophysical characterization of model human Kras promoter sequence G-quadruplexes formed by a 30-nt WT sequence and seven 30mer mutant sequences having one or more G→A or G→T mutations at positions 8, 15,
22, 24, 27, and/or 28. The model WT and mutant quadruplexes were studied using
Circular Dichroism spectroscopy, CD, Differential Scanning Calorimetry, DSC,
Isothermal Titration Calorimetry, ITC, Analytical Ultracentrifugation, AUC, and
molecular modeling. The CD results indicate that all of the model K-ras (WT and
mutant) sequences studied here fold into mixtures of intramolecular, predominantly
parallel, stranded G-quadruplexes. DSC experiments demonstrate that the K-ras WT
sequence folds into a mixture of at least two thermodynamically unique conformers with
the two overlapping melting transitions having Tm values of 58.5 °C and 71.2 °C. All
seven mutant K-ras sequences were also found to form quadruplex mixtures containing at
least two folded conformers having different thermal stabilities. Analytical
ultracentrifugation experiments demonstrated that the K-ras WT promoter sequence folds
into a compact structure (presumably a G-quadruplex) with a sedimentation coefficient of
2.4 S. Hydropro calculations for the monomeric WT K-ras G-quadruplex yield a
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theoretical sedimentation coefficient of 2.2 S. In comparison to simpler G-quadruplex
forming sequences, e.g c-MYC or even Bcl-2, formation of stable K-ras promoter
sequence G-quadruplexes requires the incorporation of large lateral or end loops and/or a
corner backbone kinked base. These results seem to indicate that G-quadruplex motifs
may occur more commonly than previously thought.
Introduction
Pancreatic Cancer is the 4th leading cause of cancer death in the United States (1,
2). In 2006 there were 33,730 new diagnoses of pancreatic cancer, and 32,300 deaths
resulting from pancreatic cancer (1, 2). The prevalence of recurrence of pancreatic
tumors after surgery is extremely high and the lack of efficacy of current anti-pancreatic
cancer therapeutics highlights the importance of developing new molecular targets for
pancreatic cancer treatment (3). As with other forms of cancer, the development of
pancreatic cancer is genetically complex (4-7). Because of this genetic complexity, it has
been difficult to identify a genetic target that can be utilized to impact pancreatic
carcinogenesis. However, in more than 90% of pancreatic tumors the K-ras protooncogene is mutated and overexpressed making it an attractive target for anticancer drug
design (2, 8, 9) (1, 10-13).
The overexpression of the K-ras oncogene is associated with cancers that are
more aggressive and have shorter survival rates such as lung, breast, prostate, colorectal,
skin, and most importantly pancreatic cancer (10, 12). The one year survival rate of a
patient with pancreatic cancer is less than 20% and five year survival rate less than 5%
which establishes it as the fourth leading cause of cancer related deaths in the United
States (1, 10).
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The drug targeting of unique higher-order DNA structures, e.g. G-quadruplex
motifs represent alternatives to DNA sequence recognition. Binding small molecules to
quadruplex DNA has been demonstrated to downregulate the expression of oncogenes
such as c-MYC and Bcl-2 in vivo (14). The quadruplex DNA target has shown promise
in increasing binding specificity for anti-cancer agents over small molecules that bind in
a sequence specific manner to duplex DNA (15-18).

The c-MYC and Bcl-2

quadruplexes are similar to the proposed K-ras quadruplex structure with the exception
that the K-ras quadruplex has much larger disordered loops, and the presence of guanine
bases that can form “kinks”, that may provide additional drug binding domains in
comparison to the quadruplexes formed in the c-MYC and Bcl-2 genes. However, these
same large disordered loops may destabilize the G-quadruplex structure preventing the
formation of a K-ras NHE in vivo.
Recent studies have suggested that the K-ras oncogene contains a nuclease
hypersensitivity element upstream from its promoter region that is capable of forming a
G-quadruplex (19). At this point it is uncertain whether or not these sequences can form
stable unimolecular structures. Although the human K-ras promoter sequence is rich in
guanine, G-quadruplexes formed by this sequence would necessarily incorporate large
destabilizing lateral loop regions and/or “kinks” in the corner backbone between the
stacked G-tetrads. Because of the role this gene plays in pancreatic cancer, it is essential
to have a clear understanding of whether or not this promoter forms a G-quadruplex in
vivo. The impact of these large loops on quadruplex stability, as well as the potential for
forming a physiologically relevant quadruplex in the K-ras NHE is the focus of this
study.
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In this study we performed a biophysical characterization of the WT and 7 mutant
K-ras P1 promoter sequences using DSC, CD, ITC, AUC, and PAGE techniques. The
initial focus of this study was to determine the structure and stability of the G-rich WT Kras promoter sequence. For this sequence to fold into a G-quadruplex structure it must
necessarily incorporate a large lateral loop and/or a “kink” structure. This polypurine
sequence was found to exist in solution as an ensemble of intramolecular G-quadruplex
motifs. We also performed additional studies on seven mutant sequences that were
created to simplify and characterize the number of folded species in equilibrium in dilute
solutions. We also performed computational studies that modeled the K-ras WT and
mutant constructs. These theoretical models are consistent with our proposed ensemble
of G-quadruplex structures as well as a single structure proposed by Cogoi et al.
Materials and Methods
The native (WT) K-ras and 30-mer oligonucleotide sequences were obtained from
Oligos Etc (Wilsonville, OR). The sequences of the WT and seven mutated constructs
shown in Table 4.1.
Table 4.1
Sequence
K-ras WT
K-G8A
K-G8T
K-G22Mutant
K-8-15-22Mut
K-G22mut1
K-G22mut2
K-G22mut3

K-ras Model P1 Promoter Polypurine Oligonucleotide Sequences.
5'5'5'5'5'5'5'5'-

1
G
G
G
G
G
G
G
G

2
G
G
G
G
G
G
G
G

3
G
G
G
G
G
G
G
G

C
C
C
C
C
C
C
C

4 5
G
G
G
G
G
G
G
G

6
G
G
G
G
G
G
G
G

T
T
T
T
T
T
T
T

7 8
G
A
T
G
A
G
G
G

T
T
T
T
T
T
T
T

9 10
G
G
G
G
G
G
G
G

11
G
G
G
G
G
G
G
G

12
G
G
G
G
G
G
G
G

13
A
A
A
A
A
A
A
A

14
A
A
A
A
A
A
A
A

15
G
G
G
G
A
G
G
G

16
A
A
A
A
A
A
A
A

17
G
G
G
G
G
G
G
G

18
G
G
G
G
G
G
G
G

19
G
G
G
G
G
G
G
G

20
A
A
A
A
A
A
A
A

21
A
A
A
A
A
A
A
A

22
G
G
G
A
A
A
A
A

23
A
A
A
A
A
A
A
A

24
G
G
G
G
G
G
A
A

25
G
G
G
G
G
G
G
A

26
G
G
G
G
G
G
G
G

27
G
G
G
G
G
A
G
G

28
G
G
G
G
G
A
A
G

29
A
A
A
A
A
A
A
A

30
G
G
G
G
G
G
G
G

3'
3'
3'
3'
3'
3'
3'
3'

The 30mer stock solutions were prepared by dissolution of weighed amounts of
lyophilized oligonucleotide into [K+] BPES buffer at a single salt concentration of 130
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mM [K+] and pH 7.0 (20). Approximately 1 mL of the oligonucleotide was exhaustively
dialyzed (1000 molecular-weight cutoff membrane) with two changes of buffer solution
(1 L, 24h each) at 4°C. The concentrations of all DNA solutions were verified using
ultraviolet-visible spectrophotometry (UV-vis) and molar extinction coefficients
determined by using a nearest-neighbor method for single stranded DNA (1). The
extinction coefficients calculated for the WT oligonucleotide sequences at 260 nm are
listed in Table 4.2.
Table 4.2

Molar Extinction coefficients for the WT and Mutant K-ras 30mer
oligonucleotides calculated using the nearest neighbor method.

Ε260 (M-1cm-1)

Oligonucleotide
WT

317400

K-G-8 (A)

320700

K-G-8 (T)

314800

K-G-22

318100

K-G-8-15-22

322100

K-G22 Mut1

32190

K-G22 Mut2

321900

K-G22 Mut3

321900

TMPyP4 was obtained from Frontier Scientific (Logan, UT). All TMPyP4
solutions were prepared by dissolution of a known amount of TMPyP4 into a measured
volume of the dialysate buffer solution from the corresponding oligonucleotide. All
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TMPyP4 concentrations were verified using UV-vis with molar extinction coefficient of
ε424=2.26 X 105 M-1cm-1 found in the literature (21).
Results
Prior to this projects inception there were no clear or definitive reports that
confirmed the formation of a stable G-quadruplex in the P1 promoter region of the K-ras
oncogene. In comparison to the c-MYC and Bcl-2 G-quadruplex forming sequences the
K-ras sequence is more complicated and in order for a stable G-quadruplex to form
within the K-ras promoter region the inclusion of a large lateral loop or a “kinked”
backbone is required. While our preliminary DSC and CD experiments were underway,
Cogoi et al reported using DMS footprinting and CD methods that the K-ras promoter
sequence formed a single stable G-quadruplex that included a “kink” and a large lateral
loop in its structure (19). A “kink” is best described as a single unstructured base that
between two guanine tetrads, i.e. the base is not involved in the G-tetrad nor is it involved
in a lateral/end loop, as depicted in Figure 4.1. Figure 4.1 demonstrates the kink formed
by run2 of guanines in the WT sequence seen in Table 4.1. G5, G6, and G8 are involved
in the G-quadruplex structure while T7 is involved in a “kink” that is kicked out between
the G-tetrad formed by G8 and G6.
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Figure 4.1

Schematic representation of a single folded conformation of the WT K-ras
Promoter sequence including a large lateral loop and “kink”. G5, G6, and
G8 (red balls) are involved in the G-quadruplex structure with base T7
(blue ball) involved in a single base “kink”.

We report here one of the first studies that establishes that the K-ras WT and
mutant promoter pyrimidine rich constructs can stable G-quadruplex structures. The
mutants were created in an effort to simplify the conformational equilibrium within the
K-ras promoter G-rich sequence as well as establish the possible inclusion of these
“kinks” into the G-quadruplex structure. We previously have reported on the
deconvolution of the WT c-MYC promoter sequences as well as the WT Bcl-2 promoter
sequence using CD, DSC, molecular modeling, and other biophysical techniques (20, 2225). From these subsequent mutations we were able to summarize the c-MYC WT
36mer is an equilibrium of a 1-6-1 and 1-2-1 mutant (23, 24, 26). Bcl-2 incorporates
large lateral/end loops however neither c-MYC nor Bcl-2 exhibit these kink possibilities.
The K-ras promoter region sequence can form G-quadruplex structures similar to those
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found in other promoter regions such as Bcl-2 and c-MYC, however the k-ras is more
complex than both these well characterized promoter region sequences.
The CD spectra for the K-ras WT and 6 mutant 30mer constructs in 130 mM [K+]
BPES exhibit a maximum molar ellipticity at 265 nm and a minimum in molar ellipticity
at 244. Figure 4.2 shows the overlapping spectra for the K-ras WT promoter sequence
(30mer) and the c-MYC WT P1 promoter sequence (36mer) in 130 mM [K+] BPES at
pH 7.0.
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CD spectra for WT c-MYC (36mer) and K-ras (30mer) promoter sequences
in 130 mM [K+] BPES buffer at pH 7.0 (23, 26).

The K-ras and c-MYC CD signatures are nearly identical and are consistent with
previously published spectra for a “classical” intramolecular parallel stranded Gquadruplex DNA (20, 23, 27). The K-ras WT and K-G22 mutant also exhibit similar,
nearly completely overlapping CD spectra whereas K-G22MUT 1, K-G22MUT2, KG22MUT3 all exhibit similar regions of maximum/minimum molar ellipticities however
there is an attenuation at the 265 nm peak in comparison to the WT. It is interesting to
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note that the CD spectra for the K-G8-15-22 and K-G8 mutants are consistent with a
predominantly parallel folded structure however they exhibit a slight shoulder in the 290295 nm region which is comparable to the spectra for an intramolecular antiparallel Gquadruplex structure. The CD spectrum for the WT and each of the mutants is the
concentration of the weighted average of the CD spectra for the individual folded species
present in solution. Therefore it should be noted the spectra for each of the mutants is for
the ensemble of possible folded structures in equilibrium in dilute solutions.
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Figure 4.3
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CD spectra for WT and all seven mutant K-ras (30mer) promoter sequences
in 130 mM [K+] BPES buffer at pH 7.0.

The results of the DSC and CD experiments present a consistent picture regarding
the structure and stability of the WT and seven mutant model G-quadruplex forming Kras promoter oligonucleotides. We have found that the WT sequence folds into at least
two unique structural quadruplexes with different thermal stabilities. We have also shown
that mutant K-G8, K-G22, and K-G8-15-22, which have G→A mutations in bases
74

presumed to be in the lateral loops, exhibit thermal stabilities that are similar to two
conformers present in the WT solution however there are noticeable differences between
the relative concentrations of folded species in equilibrium when comparing the mutants
and the WT melting profiles. These G→A mutations were made in order to simplify the
explanation of the predominant conformers in equilibrium in dilute solutions or to
validate the use of a “kink “or large lateral loop as a possible stable G-quadruplex folding
characteristic. Presumably, the implemented base mutations effect the stabilities and
change the folding topologies of the G-quadruplexes present in equilibrium by one of two
mechanisms 1) a percentage of the G-quadruplex structures involve the incorporation of
these “kinked” out bases in their folding topology, or 2) the mutation from a G→A base
effects the lateral loop conformation and alters the overall stability of the structure in
comparison to those found within the WT oligonucleotide solutions. Either one of these
mutations may cause a decrease in G-quadruplex structure stability and shift the
equilibrium of folded structures to favor a different predominant folding topology.
DSC thermal melting profiles for the WT 30-mer purine rich K-ras promoter
region oligonucleotide sequence as well as the K-G8A, K-G8T, K-G22, and K-G8-15-22
mutant sequences are shown in Figures 4.4-4.8, respectively. These melting transitions
have been deconvoluted into the least number of “two-state” transitions needed to fit the
thermogram within expected experimental error as shown in Figure 4.4 for the WT K-ras
sequence.
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DSC thermogram for the thermal denaturation of the WT K-ras 30mer
sequence in 130 mM [K+] BPES buffer at pH 7.0. The raw excess heat
capacity has been deconvoluted into two independent “two state”
processes. The solid black curve is for the raw excess heat capacity
superimposed with the composite curves (dashed grey lines) for the two
overlapping “two-state” transitions. The Tm values for the two melting
transitions are 58.97 °C and 71.59 °C.

The WT thermogram is comprised of an asymmetric peak that has been fit for two
overlapping independent “two state” transitions. The two overlapping melting transitions
for the WT sequence exhibit Tm values of 58.97 °C and 71.59 °C. The Tm values for the
WT K-ras 30mer independent melting profiles as well as the seven mutants are listed in
Table 1. The WT raw excess heat capacity exhibited a slight shoulder with a Tm of
approximately 83 °C. The observed asymmetric shoulder was attributed to the presence
of a small percentage of intramolecular G-quadruplex structures that can be described as
an equilibrium between possible dimers, tetramers, or G-wires which are all
combinations of one or more G-rich sequences. The high melting species only comprised
roughly 5% of the total structure concentration and was removed with a baseline
correction because it did not accurately describe the mixtures of intermolecular Gquadruplexes we are trying to characterize.
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Table 4.3

DSC derived Tm values for the WT and mutant K-ras promoter sequences.
130mM [K+]BPES

Tm1 (°C)

Tm2 (°C)

WT

59.0

71.6

K-G-8 (A)

57.0

68.0

K-G-8 (T)

57.2

79.3

K-G-22

58.1

69.8

K-G-8-15-22

53.7

68.0

K-G22 Mut1

54.8

69.8

K-G22 Mut2

55.1

69.9

K-G22 Mut3

55.4

69.7

The relative concentrations as well as the Tm values for the two overlapping
melting transitions are similar for the WT and the single base K-G22 mutant. Mutant KG22 is comprised of an asymmetric peak, similar to the WT, that is best fit for two
independent “two-state” transition as shown in Figure 4.5 exhibiting Tm values of 58.05
°C and 69.82 °C.
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Figure 4.5

DSC thermogram for the thermal denaturation of the K-ras K-G22 mutant
30mer sequence in 130 mM [K+] BPES buffer at pH 7.0. The raw excess
heat capacity has been deconvoluted into two independent “two state”
processes. The solid black curve is for the raw excess heat capacity
superimposed with the composite curves (dashed grey lines) for the two
overlapping “two-state” transitions. The Tm values for the two melting
transitions are 58.05 °C and 69.82 °C.

DSC thermal melting profiles for the single base mutants K-G8A, K-G8T, and
three base mutant K-G8-15-22 30mer constructs are however notably different in
comparison to the WT profiles. Mutant K-G8A is comprised of an asymmetric peak that
is best fit for two independent “two-state” transition as shown in Figure 4.6 exhibiting
Tm values of 56.99 °C and 68.01 °C as opposed to Mutant K-G8T is best fit for two
independent “two-state” transition as shown in Figure 4.7 exhibiting Tm values of 57.28
°C and 79.32 °C.
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DSC thermogram for the thermal denaturation of the K-ras K-G8A mutant
30mer sequence in 130 mM [K+] BPES buffer at pH 7.0. The raw excess
heat capacity has been deconvoluted into two independent “two state”
processes. The solid black curve is for the raw excess heat capacity
superimposed with the composite curves (dashed grey lines) for the two
overlapping “two-state” transitions. The Tm values for the two melting
transitions are 56.99 °C and 68.01 °C.
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Figure 4.7

DSC thermogram for the thermal denaturation of the K-ras K-G8T mutant
30mer sequence in 130 mM [K+] BPES buffer at pH 7.0. The raw excess
heat capacity has been deconvoluted into two independent “two state”
processes. The solid black curve is for the raw excess heat capacity
superimposed with the composite curves (dashed grey lines) for the two
overlapping “two-state” transitions. The Tm values for the two melting
transitions are 57.28 °C and 79.32 °C.
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Mutant K-G8-15-22 is best fit for only two independent “two-state” transitions
with Tm values of 53.69 °C and 68.02 °C. The Tms and relative concentrations of
uniquely folded species of the K-G8-15-22 mutant construct are similar to those of the KG8A mutant, as seen in Figure 4.8.
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Figure 4.8

DSC thermogram for the thermal denaturation of the K-ras K-G8-15-22
mutant 30mer sequence in 130 mM [K+] BPES buffer at pH 7.0. The raw
excess heat capacity has been deconvoluted into two independent “two
state” processes. The solid black curve is for the raw excess heat capacity
superimposed with the composite curves (dashed grey lines) for the two
overlapping “two-state” transitions. The Tm values for the two melting
transitions are 53.69 °C and 68.02 °C.

The aforementioned mutants were created in order to probe the possible role of
these single guanine bases that are one base in distance away (5’ or 3’) from a
consecutive run of 2 or more guanines i.e. these single bases are not themselves in a
consecutive run of guanines. In addition to these single guanine base mutations, three
additional mutants were synthesized to probe which three (the first three consecutive, the
middle three consecutive, or the last three consecutive) guanines are potentially
incorporated in the stable G-quadruplex structure from the consecutive run of 5 guanines
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at the 5’ end of the WT construct. K-G22Mut1, K-G22Mut2, and K-G22MUT3
sequences are homologous to the WT sequence except base G22 in combination with
either G27 and 28, G24 and G28, or G24 and G25 respectively, were mutated to
determine which three consecutive guanines are incorporated into the G-quadruplex
structure. Surprisingly, DSC results indicate that the there is a negligible difference
between the thermal stabilities and the excess heat capacities of the three mutants. Figure
4.9 depicts the superimposed melting curves for the WT K-ras 30mer construct and the
K-G22MUT1. K-G22MUT2, and K-G22MUT3 sequences. The thermal melting profiles
for the K-G22MUT1, K-G22MUT2, and K-G22MUT3 are nearly identical to each other.
However, the distribution of folded species for these three mutants in comparison to the
WT is notably different. The predominant conformer found in the WT is the higher
melting conformer, whereas in the three K-G22Mutants the lower melting species is the
predominant conformer.
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Figure 4.9

DSC thermograms for the thermal denaturation of the K-ras WT, KG22Mut1, K-G22Mut2, and K-G22Mut3 30mer sequences in 130 mM
[K+] BPES buffer at pH 7.0. The raw excess heat capacity has been
deconvoluted into two independent “two state” processes (data not shown).
The Tm values for three mutant constructs are similar to each other and are
comparable to the Tm values for the two melting transitions in the WT.

Typical ITC data obtained for the titration of the K-ras WT 30mer construct with
TMPyP4 at 25 °C in 130 mM [K+] BPES buffer at pH 7.0 are shown in 4.10. After
making corrections for blank heat effects, baseline, and titrant dilution, the correct heat
data were fit using a non-linear regression algorithm to obtain the best fit parameters for
the equilibrium constant(s), K, enthalpy change(s), ∆H, and reaction stoichiometry, n, for
the formation of the G-quadruplex DNA/TMPyP4 complex. The binding thermograms
for the interaction of the K-ras WT 30mer construct and TMPyP4 require a complicated
model that exhibits two binding modes with each binding mode exhibiting two equivalent
sites. At saturation the binding stoichiometry of TMPyP4 to G-quadruplex DNA is 4:1.
The best fit parameters for the binding of TMPyP4 to the K-ras WT 30mer G-quadruplex
are listed in Table 3 along with the best fit parameters for TMPyP4 binding to the WT cMYC (36mer) and the WT Bcl-2 (39mer) promoter sequences. The values listed for the
interaction of TMPyP4 with all three of these WT promoter region G-quadruplexes is
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similar and demonstrates that the WT K-ras construct is capable of binding TMPyP4 with
similar binding modes and affinities.
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Table 4.4

Typical ITC titration data (◊) and nonlinear regression fit (solid line) are
shown for a titration experiments in which a dilute solution of porphyrin
was added to a dilute solution of the annealed oligonucleotide in the
calorimeter cell.
ITC Derived Thermodynamic Parameters for the binding of TMPyP4 to the
WT 30mer K-ras G-quadruplex.* These data are for the interaction of
TMPyP4 with the c-MYCWT 36mer G-quadruplex (20).+ These data are
for the interaction of TMPyP4 with the Bcl-2 WT 39mer G-quadruplex (25)

Non-denaturing polyacrylamide gel electrophoresis experiments were performed
on the annealed and unannealed K-ras quadruplex construct samples. The annealed cMYC and Bcl-2 samples were evaluated for comparison. The gel clearly contains
multiple bands for both the unannealed and annealed samples of all three
oligonucleotides, as seen in Figure 4.11. The unannealed K-ras sample shows more
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intense, higher molecular weight bands, in comparison to the annealed K-ras sample. The
intramolecular (monomer) quadruplex band for all three annealed oligos lies between the
20 and 30 bp DNA step bands. This is consistent with an oligonucleotide that containing
approximately 50 bases (25 bp).. In addition to the darkest band at approximately 25 bp,
there are also several minor higher molecular weight bands in all of the samples, and in
the case of K-ras some larger than the 100 bp ladder band. These higher molecular weight
and more intense bands have been previously reported Hurley et al as being bands for
various intermolecular G-quadruplex structures [42]. PAGE experiments were also
performed on the seven mutants (Data not shown). The K-G22, K-G8A, and K-G8T
mutants exhibited bands similar to those resolved in the annealed WT K-ras 30mer
construct.
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Bcl-2 Annealed

c-MYC Annealed

K-ras Unannealed

K-ras Annealed

100
50
30
20
10
Figure 4.11

PAGE mobilities of the WT K-ras (30mer) unannealed, WT K-ras (30mer)
annealed, WT c-MYC (36mer), and WT Bcl-2 (39mer) promoter sequences
in 20% polyacrylamide gel.

The darkest bands were observed between the 20 and 30 bp DNA step bands as
well as several minor higher molecular weight bands that were not resolved as clearly
with minor tailing. These higher molecular weight bands are also evidence that these
mutants form various intermolecular folded structures similar to the WT K-ras 30mer.
The K-G22Mut1, K-G22Mut2, and K-G22Mut3 however only display a single band
between the 20 and 30 bp DNA steps. There are no additional bands resolved for these
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three mutants indicating only single stranded intermolecular folded structures are formed
that are relatively the same size as the WT K-ras 30mer, WT Bcl-2 39mer and c-MYC
WT 36mer.
Analytical ultracentrifugation experiments on the K-ras oligonucleotide construct
demonstrated that the unannealed sample is very polydisperse, while the annealed K-ras
sample has two principle species having sedimentation coefficients of 2.4 and 4.9 S
respectively, as seen in Figure 4.12 and Figure 4.13. The large 2.4 S peak in the C(S) vs S
plot is consistent with a species having a molecular weight of approximately 10,000
Daltons.
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Superimposed Analytical ultracentrifugation experimental results for the
annealed and unannealed WT K-ras 30mer.

The K-ras model oligonucleotide has a Mw of 9612 Daltons. The WT c-MYC (36mer)
and WT Bcl-2 (39mer) G-rich promoter sequences (previously shown to form stable Gquadruplex motifs) were again analyzed for comparison (Figure 4.13). The c-MYC and
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Bcl-2 oncogene G-quadruplexes both show similar sedimentation profiles to the K-ras
model oligonucleotide. The sedimentation data are summarized in Table 4.5.
Table 4.5

Summary Of The SEDFIT Analysis Of The Analytical Centrifugation
Experiments.1 The measured sedimentation coefficients are consistent with
a monomeric species and are the maxima for the first peak in the C(S) vs. S
plot (Figure 4.13). 2 The measured sedimentation coefficients are
approximately consistent with a dimeric species and are the maxima for the
second peak in the C(S) vs. S plot (Figure 4.13). 3 The calculated
sedimentation coefficient for the c-MYC 22-mer was obtained from the
published NMR structure for this quadruplex using the PDB file and the
appropriate values for the solution density and partial specific volume. The
sedimentation coefficients listed for the other quadruplexes are estimates
assuming that the shape factor is unchanged from the 22-mer standard.
Molecular
Wt.

Sed. Coeff.1
(measured)

Sed. Coeff.2
(measured)

Sed Coeff.3
(HydroPro)

K-ras (30-mer)

9,612

2.4 S

4.9 S

2.2 S

c-MYC (22-mer)

6,991

na

na

1.6 S

c-MYC (36-mer)

11,519

2.4 S

5.2 S

2.6 S

Bcl-2 (39-mer)

12,431

2.7 S

5.5 S

2.9 S

Promoter

All three of the oncogene promoter region sequences demonstrate two peaks with
the predominant peak in the K-Ras, c-MYC, and Bcl-2 constructs attributed to a
monomeric folded species with a molecular weight consistent with a single stranded
intramolecular motif. The second broad peak is attributed a dimeric species with a
molecular weight that is consistent with and intermolecular structure involving two Grich strands.
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Figure 4.13

Superimposed Analytical ultracentrifugation experimental results for the
WT K-ras 30mer (2.4S), WT c-MYC 36mer (2.4S), and the WT Bcl-2
39mer (2.7S).

Theoretical G-quadruplex structures were developed using computational
modeling methods to explain a number of the possible folding topologies in the K-ras
WT promoter sequence. The minimized structures for five of the folding topologies for
the WT K-ras promoter sequence are shown in Figures 4.14 through 4.18. These five
structures were modeled based upon their sequence and were predicted to be the most
stable or predominant structures base upon previous c-MYC and Bcl-2 folding
topologies. We assigned each of the consecutive runs of guanines (>3 guanine bases or
>2 guanine bases including a kink) in the K-ras WT promoter sequence a number from 1
to 5. There are 5 consecutive runs of guanines that can be involved in G-quadruplex
formation. Run 2 involves the kink and run 5 involves 5 guanines that can be
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theoretically be involved in G-quadruplex formation. Based upon this assignment the WT
can be described as: Run 1 involving G1-G3, Run 2 G5-G8 (including T7 as a kinked out
base), Run 3 G10-G12, Run 4 G-17-G-19, and Run5 G-24-G26. Therefore model 1-2-34 includes runs 1, 2 (with a kink), 3, and 5 of guanines in the minimized structure, as seen
in Figure 4.14.

Figure 4.14

.Schematic representation of the WT 1234 folding topology. This possible
structure is shown from three different perspectives. The upper left panel is
a view of the WT 1234 from the top of the stacked G-tetrad core. The
lower panel is a view of the same WT1234 model from the side view with
the T7 “kink” on the left side of the model. The top right inset is a close up
view of Run 2 that includes the kink with bases G5, G6, T7, and G8.
89

Figure 4.15 depicts the folding topology reported by Cogoi et al as the
predominant structure formed by the K-ras promoter region sequence using DMS
Footprinting methods.

Figure 4.15

Schematic representation of the WT 1235 folding topology. This possible
structure is shown from three different perspectives. The left panel is a
view of the WT 1235 from the top of the stacked G-tetrad core. The lower
right inset is a close up view of Run 2 that includes the kink with bases G5,
G6, T7, and G8. The upper right panel is a view of the same WT1235
model from the side view with the T7 “kink” on the left side of the model
and the large lateral loop to the right.
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Figure 4.16

Schematic representation of the WT 1245 folding topology. Depicted is a
side view of the WT 1245 with the T7 “kink” in the right side of the figure
with the large 8 base lateral loop to the far right.

Figure 4.17

Schematic representation of the WT 1345 folding topology. Depicted is a
side view of the WT 1345 with the T7 “kink” in the right side of the figure
with the large 8 base lateral loop to the far right.
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Figure 4.18

Schematic representation of the WT 2345 folding topology. Depicted is a
side view of the WT 2345 with the T7 “kink” in the right side of the figure
with the large 8 base lateral loop to the far right.

The conformational energies for the 5WT model structures as well as the 4 of the
mutant structures are given in Table 5. The Van Der Waal contribution to the total
minimization energies is relatively similar for all WT and mutant models whereas the
electrostatic interactions are the larger contribution, and vary, with between al the WT
and mutant the models. The WT model with the lowest conformational energy was the
WT 1,2,3,5. This model includes Run 1 involving G1-G3, Run 2 G5-G8 (including T7 as
a kinked out base), Run 3 G10-G12, , and Run5 G-24-G26. The mutant model with the
lowest conformation energy was the K-G22 MUT 1, 2, 3, 5 as well which again involves
Run 1 G1-G3, Run 2 G5-G8 (including T7 as a kinked out base), Run 3 G10-G12, Run 4
G-17-G-19, and Run5 G-24-G26.
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Table 4.6

Molecular modeling derived energy minimization values for the WT and
four mutant K-ras constructs.
Implicit solvent
(J/Kmol)

K-G-8T
K-G-8A
K-G8-15-22
K-G22

WT

Explicit solvent & Counterions
(J/Kmol)

# H2O

1234

VDW
-265.9

Electrostatic
-1703.5

Total
-1969

VDW Electrostatic
-164.9
-2714.9

Total
-2879.8

6360

1235

-234.1

-1680.1

-1914

-185.1

-3005.9

-3191.0

3503

1234

-228.7

-2229.2

-2458

-160.6

-3054.4

-3215.0

5235

1235

-248.9

-2233.9

-2483

-185.9

-3089.9

-3275.8

3585

1345

-183.1

-3712.8

-3896.0

-135.1

-3076.6

-3211.6

4720

1234

-178.3

-3830.3

-4008.6

-116.2

-3207.8

-3324.0

5329

1235

-188.7

-4152.1

-4340.8

-167.5

-3525.6

-3693.1

4207

1245

-205.5

-3550.5

-3756.0

-164.4

-2914.3

-3078.7

4575

1234

-183.3

-3783.9

-3967.2

-148.3

-3095.2

-3243.5

5362

1235

-208.5

-4040.6

-4249.1

-182.7

-3336.9

-3519.6

3561

1245

-202.6

-3625.9

-3828.5

-186.2

-2929.6

-3115.8

4289

1345

-198.2

-3810.3

-4008.5

-174.8

-3225.4

-3400.2

4559

2345

-200.4

-3555.5

-3755.9

-192.8

-2958.0

-3150.8

4203

Discussion
Prior to 2006 there were no reports regarding the structure and stability of the WT
K-ras guanine rich promoter region sequence. Further investigation of the WT K-ras
promoter sequence revealed that the guanine rich promoter region could potentially form
a stable higher order G-quadruplex DNA structure. In order for the K-ras WT promoter
sequence to form a stable G-quadruplex it must necessarily incorporate a combination of
large lateral loops or “kinks” in the G-quadruplex backbone, which by previous reports
would suggest a reduced ability for this region to form a stable g-quadruplex. We present
here a more in depth characterization of the K-ras WT promoter region purine rich
sequence with results that are consistent with those reported by Cogoi et al (19). The use
of multiple biophysical and thermodynamic techniques all provide evidence for formation
of stable G-quadruplex structure by the K-ras WT and mutant promoter region sequences.
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We performed concentration dependent CD experiments on the WT K-ras 20mer
construct as well as a TG4T construct (Data not shown). TG4T was selected as the
control construct for a tetramolecular (intermolecular) G-quadruplex since there is no
way for it to fold into a unimolecular (intermolecular) G-quadruplex. The molar
ellipticities of TG4T and WT K-ras 30mer constructs are then compared to determine if
the spectrum changes as a function of oligonucleotide concentration. It is not possible for
the TG4T construct to form an intramolecular G-quadruplex motif therefore the TG4T
concentration will have an effect on the G-quadruplex equilibrium for the tetrameric
species. A change in the TG4T concentration over a large enough range will produce an
obvious change in the molar ellipticity of the TG4T sample while the predicted effect of
concentration of unimolecular quadruplex equilibrium would be minimal, if at all. Our
experiment using TG4T suggests that in the concentration range explored, the use of CD
is not sensitive enough to identify the molecularity of the species in solution, Obviously
the concentration range used in these experiments is not sufficiently broad to explore this
equilibrium effect.
Our initial focus of this study was to verify and explore the structure and stability
of K-ras WT promoter purine rich region and its ability to fold into a G-quadruplex
structure. The average molar ellipticity for the K-ras WT 30mer dilute solutions
produces a spectrum that is best described as predominantly an intramolecular parallel
stranded G-quadruplex. The K-ras WT 30mer spectrum is nearly identical to that of the
c-MYC WT 36mer G-quadruplex that has been well characterized previously (figure and
ref). PAGE experiments were performed on the unannealed and annealed K-ras WT
30mer constructs and the results demonstrate that the unannealed K-ras WT 30mer is
polydisperse and in equilibrium between intermolecular and intramolecular folded
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structures. In comparison to our gel results, our interpretation of Cogoi et als gel data is
that their gel results indicate the formation of intermolecular G-quadruplex structures
under their experimental conditions (19). While they were correct in proposing that the
K-ras promoter quadruplex could be targeted in order to regulate K-ras expression, it is
clear from their data and ours that the K-ras folding equilibrium is not as simple as other
previously described G-rich promoter regions. Our PAGE results for the annealed K-ras
WT 30 mer and c-MYC WT 36mer also demonstrate similar electrophoretic mobilities.
The presence of large endothermic denaturation peaks and their relative Tm
values obtained from our DSC experiments indicate the K-ras WT 30mer oligonucleotide
construct forms stable higher order motifs. The K-ras WT 30mer is very stable and is
best fit for two overlapping independent “two state” melting transitions with Tm values
of 58.97 °C and 71.59 °C. AUC analysis of the K-ras WT 30mer reveals that the stable
(annealed) folded structure was predicted to and experimentally exhibits a sedimentation
coefficient that is similar to sedimentation coefficients of the BcL-2 and c-MYC Gquadruplexes.
The ITC results present an energetic binding profile for the interaction of
TMPyP4 with the K-Ras WT 30mer construct that is similar to the energetic binding
profiles of TMPyP4 with the c-MYC and Bcl-2 (WT and mutant) promoter regions Gquadruplexes. The K-ras WT 30mer exhibits to distinct binding modes for TMPyP4 with
a saturation stoichiometry 4:1 for TMPyP4 to DNA. The first, higher affinity, binding
mode is entropically driven where the second binding mode, with lower affinity, is
enthalpically driven. These modes were described previously as Mode 1 and Mode 2
binding, with each one of these involving two binding sites, each binding 1 mole of
TMPyP4. The relative affinities for the binding of TMPyP4 for both modes of binding
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are comparable to those for the affinity of TMPyP4 to the c-MYC and Bcl-2 WT Gquadruplexes. The energetic profile for the first TMPyP4 binding mode is indicative of an
entropically driven process. In the case of hydrophobic ligands binding in the DNA
minor groove, water solvating the free ligand and structured water from the minor groove
are expelled resulting in a large positive change in entropy (28-32). We speculate here
that the entropy driven energetics for Mode 1 binding, typical for the binding of a
hydrophobic ligand to the exterior of duplex DNA, can be used as a model for the
exterior or end binding interactions of the TMPyP4 ligand to the top or bottom of the Gquadruplex structure. One subtle difference here between exterior binding to the Gquadruplex and minor groove binding to duplex DNA, would be that the water on the
exterior of the G-quadruplex is probably less organized than groove or spine water in
duplex DNA. The energetic profile for the second TMPyP4 binding mode is indicative
of an enthalpy driven process. In the case of the insertion of planar aromatic ligands
between the stacked bases in duplex DNA, the typical exothermic enthalpy change is
largely the result of increased π-π stacking interactions between the DNA bases and the
intercalated aromatic ligand (28-32). We speculate here that the enthalpy driven
energetics for Mode 2 binding, typical for the intercalation of a planar aromatic ligand
into duplex DNA, can be used as a model for the stacking of the TMPyP4 ligand between
G-tetrads in the G-quadruplex structure. One subtle difference would be that in duplex
intercalation there are additional consequences of intercalation, i.e. some unwinding of
the DNA duplex.
The CD, DSC, PAGE, ITC, and AUC results for the K-ras WT 30mer construct
support the formation of a stable G-quadruplex structure similar to those characterized for
the c-MYC and Bcl-2 WT and mutant purine rich sequences. The bcl-2 sequence
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involves large lateral loop regions but neither the c-MYC nor Bcl-2 sequences exhibit a
sequence with the propensity to form a kinked G-quadruplex. Cogoi et al described the
predominant K-ras G-quadruplex structure as involving guanine runs 1,2,3,and 5 by DMS
footprinting methods (19). Their model includes guanines from Run 1 G1-G3, Run 2 G5G8 (including T7 as a kinked out base), Run 3 G10-G12, and Run5 G-24-G26. The fourth
run of guanines is not protected from DMS cleavage therefore is involved in a large
lateral loop. Because this run of guanines is completely cleaved, the formation of a stable
intramolecular parallel stranded G-quadruplex must obviously include the second run of
guanines which involves a single Thymine (T7) base kink.
Our K-ras G-quadruplex WT and mutant models were created based upon our
thermodynamic results. Our studies demonstrate that the relative energy minimization
values for the 5 structures are comparable to one another however the 1235 structure has
the lowest value for the energy minimization of the structure. The electrostatic interaction
values are the main component whereas the VDW contribute a minimal amount to the
total minimization energy. Though these energy minimization values can only be used as
hypothetical models for the conformers exhibited by the WT, they are consistent with our
experimental results for our T and mutant sequences. To our knowledge, the K-ras WT
30mer construct is the first reported G-quadruplex structure that involves type of single
base loop or “kink” of the backbone in between tetrads. To date most studies indicate that
a stable G-quadruplex can only form with consecutive runs of guanines of 3 or more.
To further simplify the possible folded conformers within the K-ras promoter
sequence single base G→A mutations at bases G8, G15, and G22 were inserted to probe
whether these bases are involved in unstructured lateral loops or are incorporated in a
backbone “kink” and how they affect the overall G-quadruplex stability. Mutant K-G22
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involves the mutation of base G22 to A22. In the WT this base G22 is one base away
from the 3’ end of five guanines (i.e. Run 5). From an energetic point of view the
incorporation of G22 into a G-quadruplex by a “kink” would be predicted as not as
energetically favorable as the incorporation of the three of the consecutive guanines in
the 3’ end run. If G22 were involved in “kink” the flexibility of the two-adenine base
lateral loop may cause strain on the “kinked” out backbone structure. As predicted the
DSC and CD results for the K-G22 are very similar to those of the WT. The spectra for
the K-G22 mutant and the WT 30mer constructs are overlapping and almost
indistinguishable except at low wavelengths. DSC thermal melting profiles for both the
WT and the K-G22 display relatively similar species distributions and Tm values that are
comparable for both the low melting and high melting conformers (<2 °C). As
previously mentioned the K-G22 was one of only three constructs, two mutants and the
WT, whose raw excess heat capacity exhibited a slight shoulder. After examining the
PAGE results we removed this artifact using baseline corrections during the data fitting
process and attributed this phenomenon to a dimeric, or intermolecular, species.
The K-G8 mutant is interesting in that the relative ratios of the conformers present
in solution observed by DSC are altered with the G to A mutation. This mutation could
possibly lead to the introduction of the A into the G-tetrad and form a stable quadruplex
however we see an altered DSC thermogram in comparison to the WT with a single base
mutation. There is a notable difference in the CD spectra for the K-G8A and K-G8T
mutants. With the mutation of K-G8 to T or A we suspect that run 2 of guanines in the
WT cannot be included. One of the G-quadruplexes formed by the WT must obviously
be formed using G5, G6, and G8 (run 2). Once G8 is mutated to A8 it no longer can
hydrogen bond to the A in the same manner as the guanine at position 8 therefore the
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stability markedly decreases. When G8 is mutated to a T the ability to Hoogsteen
hydrogen bond with the guanines in the tetrad is no longer possible so the G-quadruplex
is forced to adopt a different folding topology. The equilibrium is shifted from one
predominant structure to another and the result is a G-quadruplex motif with an increased
Tm in comparison to the highest melting conformer in the WT. PAGE results indicate
the presence of intramolecular and intermolecular species with the G8 mutants. At this
time is it not possible to discriminate whether the higher melting transition can be
attributed to an intermolecular species or if it is attributed to the forced folding of a more
stable G-quadruplex. This phenomenon is not only observed in DSC and PAGE but are
reflected in the energy minimization values in Table 5 (highlighted in green). Both KG8A and K-G8T exhibit minimization energies that are nearly half of those calculated for
all five of the WT conformations. These values indicate that the inserting an A or T in
place of the guanine within the G-tetrad at position 8 greatly decreases the overall
structure stability.
Mutant K-G8-15-22 was created by mutating all three bases G8, G15, and G22 to
adenines. When all three bases are mutated from a G→A there is a reduction in the Tm
values of both melting profiles in comparison to the WT. The relative concentrations of
these two species are also markedly different than those of the other mutants and the WT.
When the K-G8-15-2 mutant is modeled the minimization energies however are not much
greater than those exhibited for the 1235 and the 1234 WT folding topologies as seen in
Table 5. When bases 8, 15, and 22 are mutated from the WT sequence the modeled
structure must involve the incorporation of Runs 1345. If we compare the minimization
energies for the K-G8-15-22 and the WT 1345 minimization energies they are relatively
similar.
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The last run of guanines in the WT sequence, run 5, has a total of 5 guanines. To
form a stable G-quadruplex comprised of 3 tetrads, a total of 12 guanines must
necessarily be incorporated. To determine which guanines are possibly involved in the
formation of the stable G-quadruplex we made three mutants where either the first three
guanines (G24-G26), the central three guanines (G25-G27), or the last three guanines
(G26-G28) are incorporated. Previous reports using other G-quadruplex constructs
indicate that the increase in loop size decreases the stability of the G-quadruplex at 130
mM [K+] which ultimately results in a decrease in Tm values for the G-quadruplex
structure. With the described mutations the K-G22MUT1 includes four unstructured
adenine bases in the lateral/end loop, K-G22MUT2 therefore includes 5 adenine bases
and K-G22MUT3 ultimately includes six adenine bases in the lateral/end loop. The
increasing number of bases in the lateral loops due to these mutations appears to have
little or no effect on the overall stability of the G-quadruplex structures in equilibrium in
the solution. The relative concentrations and Tm values for all three mutants is relatively
similar and unaffected by an increase in loop size. One possible explanation for these
results is that the decrease in stability is only observed when the lateral/end loop is
greater than a specific number of bases (~6 bases). Once the number of bases in the loop
reaches a length that is no longer energetically favorable, the flexibility and the rotational
freedom causes a reduction in stability. The length of the loops in these mutated
sequences is below this “threshold limit” and therefore does not dramatically affect the
stability as a larger loop.
The CD spectra of the K-G22MUT1, K-G22MUT2, K-G-22MUT3 and K-G8-1522 are almost identical. The spectra for these three mutants are notably attenuated at 265
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nm in comparison to the WT and K-G22 mutant. This attenuation is somewhat
unexpected; we originally predicted that one of the mutants (either K-G22MUT 1, KG22MUT2,or K-G22MUT3) would be comparable to the K-G22 Mutant and the WT
because the only additional mutations involve the 3’ (Run5) guanines. One explanation
for this discrepancy is that the remaining two guanines not involved in the formation of
the G-quadruplex in the WT are somehow interacting with and stabilizing the Gquadruplex further through a number of interactions to include: loop/tail or tail/tail, tail.
It could also be hypothesized that the unstructured mutated adenine bases change the
structure of the lateral/end loops which in turn alters the absorption of the polarized light.
The orientation and structure of the lateral/end loop changes which does not affect the
thermal stability but markedly alters the CD of the mutants in comparison to the WT.
As mentioned the minimization energies calculated using molecular modeling
techniques can only be used as models and are not as valid as biophysical experimental
results. However it must be emphasized that these models present a consistent and an
invaluable visual representation of the possible folding topologies for the WT and the
mutant K-ras constructs. From these models we can make a number of hypothesis that
can hopefully be evaluated experimentally further. The most important information we
can extract from the models is that the backbone “kink” can be stabilized in the Gquadruplex structure. We can see from Figures 4.14 through 4.17 that the G-tetrads
remain intact and the structures remain stable with the single base kink. We hypothesize
that this ‘kink” is able to be incorporated into the G-tetrad backbone only in structures
that involve Run 3 of guanines in the tetrad as well. If run 3 is not involved in the
formation of the G-quadruplex and are involved in the lateral loop, the lateral loop
becomes large and may cause strain on G8. The strain of the T7 kink and the 8 base
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lateral loop on this single guanine could potentially explain why the minimization
energies for WT 1245 are lower than those for 1234 and 1235. These models further
depict the structural complexity involved in each of the folding topologies for the K-ras
polypurine sequence. We previously reported minimized structures for the less complex
c-MYC silencer element. The number of large lateral loops and the kink involved in the
K-ras structures make them unique and their models are truly unique.
Conclusion
The K-ras WT 30mer guanine rich promoter sequence exhibits CD, AUC, and
ITC binding characteristics that are similar to those reported extensively for the c-MYC
WT 36mer and Bcl-2 WT 39mer G-quadruplexes in dilute solutions. The K-ras WT
30mer adopts at least two unique conformations in130 mM [K+] BPES buffer at pH 7.0
and binds 4:1 moles of TMPyP4 /K-ras DNA. We have discussed that DSC melting
profiles can be used to evaluate and/or deconvolute the different structural species that
might exist in equilibrium for a folded oligonucleotide. From all methods used here it is
obvious that non-core bases and non-consecutive guanines affect G-quadruplex stability
characteristics. The strength of this study lies in that stable G-quadruplex structures can
form with the incorporation of “kinks” and large lateral loops which would previously be
described as non-conventional G-quadruplex features. If the base involved in the “kink”
is mutated the WT structural equilibrium must shift to accommodate a folded structure
that involves a different combination of guanine bases in the G-quadruplex core structure.
This structural information can be used in the future to design and study the interactions
between K-ras G-quadruplex specific ligands and the most stable K-ras G-quadruplex
structures in solution.
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CHAPTER V
DSC DECONVOLUTION OF THE STRUCTURAL COMPLEXITY OF WILD TYPE
(WT) AND MUTANT K-RAS PROMOTER G-QUADRUPLEXES
Abstract
Expression of the K-ras proto-oncogene is a well known hallmark of pancreatic
cancer. We report here the results of a biophysical characterization of model human Kras promoter sequence G-quadruplexes formed by a 30-nt WT sequence and (19)
different 26-mer mutant sequences having one or more G→A or G→T mutations
throughout the length of the sequence. The model WT and mutant quadruplexes were
studied using Circular Dichroism spectroscopy, CD, Differential Scanning Calorimetry,
DSC, DMS footprinting, and molecular modeling. The CD results indicate that six of the
model K-ras mutant sequences studied here fold into mixtures of intramolecular,
predominantly parallel, stranded G-quadruplexes. The remaining mutants exhibit spectra
that are “G-quadruplex like.” DSC experiments demonstrate that all the model K-ras
mutant sequences fold into a mixture of at least two thermodynamically unique
conformers with the two overlapping melting transitions. DMS footprinting of 8 of the
K-ras model sequences as well as the WT K-ras sequence was performed at the
University of Arizona Cancer center in collaboration with Dr. Laurence Hurley. DMS
footprinting experiments reveal that only the WT and 4 of the 8 mutant sequences exhibit
G-quadruplex structure formation, consistent with CD results. Minimization energies
calculated in molecular modeling experiments are consistent with reported in Chapter 4
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for a number of conformations calculated within the WT sequence. In comparison to
simpler G-quadruplex forming sequences, e.g c-MYC or even Bcl-2, formation of stable
K-ras promoter sequence G-quadruplexes requires the incorporation of large lateral or
end loops and/or a corner backbone kinked base. These results seem to indicate that Gquadruplex motifs may occur more commonly than previously thought.
Introduction
The overexpression of the K-ras oncogene is associated with cancers that are
more aggressive and have shorter survival rates such as lung, breast, prostate, colorectal,
skin, and most importantly pancreatic cancer (1, 2). The one year survival rate of a
patient with pancreatic cancer is less than 20% and five year survival rate less than 5%
which establishes it as the fourth leading cause of cancer related deaths in the United
States (2, 3).
The drug targeting of unique higher-order DNA structures, e.g. G-quadruplex
motifs represent alternatives to DNA sequence recognition. Binding small molecules to
quadruplex DNA has been demonstrated to downregulate the expression of oncogenes
such as c-MYC and Bcl-2 in vivo (4). The quadruplex DNA target has shown promise in
increasing binding specificity for anti-cancer agents over small molecules that bind in a
sequence specific manner to duplex DNA (5-8).

The c-MYC and Bcl-2 quadruplexes

are similar to the proposed K-ras quadruplex structure with the exception that the K-ras
quadruplex has much larger disordered loops, and the presence of guanine bases that can
form “kinks”, that may provide additional drug binding domains in comparison to the
quadruplexes formed in the c-MYC and Bcl-2 genes. However, these same large
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disordered loops may destabilize the G-quadruplex structure preventing the formation of
a K-ras NHE in vivo.
We report in Chapter 4 that the K-ras oncogene contains a nuclease
hypersensitivity element upstream from its promoter region that is capable of forming a
G-quadruplex (9). G-quadruplexes formed by this sequence would necessarily
incorporate large destabilizing lateral loop regions and/or “kinks” in the corner backbone
between the stacked G-tetrads. Being able to specifically target these higher order
structures that form within the K-ras oncogene could be extremely beneficial in the
design of drugs that treat pancreatic cancer. In order to modulate the transcription of the
K-ras oncogene by drug targeting these G-quadruplex and i-Motif structures we must
better understand 1) the folding topologies and stability of these structures in solution and
2) the binding to specific structures.
In this study we performed a biophysical characterization of the WT and 19
mutant K-ras P1 promoter sequences using DSC, CD, DMS footprinting, and molecular
modeling techniques. The primary focus of this study was to determine the structure and
stability of mutant K-ras G-quadruplex sequences in an effort to simplify and describe the
number of folded species found within the K-ras WT promoter sequence. For these
sequences to fold into a number of G-quadruplex structures they must necessarily
incorporate a large lateral loop and/or a “kink” structure. This WT and 6 mutant
polypurine sequence were found to exist in solution as an ensemble of intramolecular Gquadruplex motifs. Our theoretical models are consistent with our proposed ensemble of
G-quadruplex structures as well as a single structure proposed by Cogoi et al.
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Materials and Methods
The native (WT) K-ras and mutant (MUT) 26-mer oligonucleotide sequences
were obtained from Oligos Etc (Wilsonville, OR). The sequences of the WT and five
mutated constructs shown in Scheme 1. The WT guanines are highlighted in green and
all the guanine to adenine mutations are indicated in fuchsia. These subsequent mutations
were made to simplify the number of folded species in dilute solutions. There are 5
consecutive runs of guanines that can be involved in G-quadruplex formation and these
were designate Run 1 through Run 5. Based upon this assignment the WT can be
described as: Run 1 involving G1-G3, Run 2 G5-G8 (including T7 as a kinked out base),
Run 3 G10-G12, Run 4 G-17-G-19, and Run5 G-24-G26. Mutations were made
systematically to each of the 5 runs of guanines that are exhibited in the WT as well as
base 8, base 15, and base 22, in order to probe further the role these bases play in possible
kink formation within the mutants. For example Mut2-5 has Run 2 of guanines mutated
to adenines and Mut2-5X8-15-22 is similar in sequence to Mut2-5 (where run 2 is
mutated) as well as bases G15 and G22 to eliminate the possibility of a kink. 6 mutants
were also created in order to probe the maximum number of kinks (2, 3, or 4) that may be
involved in the formation of a stable G-quadruplex.
All stock solutions were prepared by dissolution of weighed amounts of
lyophilized oligonucleotide into [K+] BPES buffer at a single salt concentration of 130
mM [K+] and pH 7.0 (10). Approximately 1 mL of the oligonucleotide was exhaustively
dialyzed (1000 molecular-weight cutoff membrane) with two changes of buffer solution
(1 L, 24h each) at 4°C. The concentrations of all DNA solutions were verified using
ultraviolet-visible spectrophotometry (UV-vis) and molar extinction coefficients
determined by using a nearest-neighbor method for single stranded DNA (1).
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Table 5.1

WT and Mutant K-ras promoter region oligonucleotide sequences.

Results
In Chapter 4 we first described the biophysical characterization of an ensemble of
stable G-quadruplex in the WT K-ras promoter region sequence. We also performed a
biophysical characterization on a number of mutant sequences in an attempt to 1)
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evaluate if a stable G-quadruplex could form in the K-ras promoter region with the
incorporation of a “kink” or large lateral loops and 2) reduce the number of possible
folded structures in dilute solutions. As previously mentioned in Chapter 4 a “kink” is
best described as a single unstructured base that between two guanine tetrads, We
previously have reported on the deconvolution of the WT c-MYC promoter sequences as
well as the WT Bcl-2 promoter sequence using CD, DSC, molecular modeling, and other
biophysical techniques (10-14). From these subsequent mutations we were able to
summarize the c-MYC WT 36mer is an equilibrium of a 1-6-1 and 1-2-1 mutant (12, 13,
15). Bcl-2 incorporates large lateral/end loops however neither c-MYC nor Bcl-2 exhibit
these kink possibilities. The K-ras promoter region sequence can form G-quadruplex
structures similar to those found in other promoter regions such as Bcl-2 and c-MYC,
however the k-ras is more complex than both these well characterized promoter region
sequences.
The CD spectra for the K-ras WT and all the 26mer constructs in 130 mM [K+]
BPES buffer at pH 7.0 are shown in Figures 5.1-5.4. The WT spectra is superimposed in
Figures 5.2-5.5 for comparison. As previously described in Chapter 4, the WT exhibits a
maximum molar ellipticity at 265 nm and a minimum in molar ellipticity at 244. Figure
5.1 shows the overlapping spectra for the K-ras WT sequence (30mer) and the mutants
Mut2-5, Mut2-5X15-22, Mut3, and Mut3-5X15-22 in 130 mM [K+] BPES at pH 7.0.
These four mutants exhibited spectra that were consistent with varying degrees of mixed
parallel/antiparallel spectral characteristics.
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Figure 5.1

CD spectra for WT K-ras (30mer) and mutants Mut2-5, Mut2-5X8-15-22,
Mut3-5, and Mut3-5X8-15-22 promoter sequences in 130 mM [K+] BPES
buffer at pH 7.0.

The K-ras WT and mutants Mut4-5, Mut4-5X15-22, Mut5, and Mut5X15-22 in
130 mM [K+] BPES buffer at pH 7.0 It is interesting to note that the CD spectra for all
four of the mutants shown in Figure 5.2 are consistent with a predominantly parallel
folded structure however they exhibit a slight shoulder in the 290-295 nm region which is
attributed to the formation of an intramolecular antiparallel G-quadruplex structure. The
CD spectrum for the WT and each of the mutants is the concentration of the weighted
average of the CD spectra for the individual folded species present in solution. Therefore
it should be noted the spectra for each of the mutants is for the ensemble of possible
folded structures in equilibrium in dilute solutions.
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CD spectra for WT K-ras (30mer) and mutants Mut4-5, Mut4-5X15-22,
Mut5, and Mut5X15-22 promoter sequences in 130 mM [K+] BPES buffer
at pH 7.0.

Figure 5.3 demonstrates the CD spectra for the WT K-ras (30mer) and mutants
Mut3-4-5Kink, Mut1-3-4-5kink, Mut5X15-22, and Mut2-4-5kink promoter sequences in
130 mM [K+] BPES buffer at pH 7.0 The three mutants were created with 3 or 4 kinks to
probe the stability of a G-quadruplex including more than one kink in its corner
backbone. The CD spectra for Mut3-4-5kink, Mut1-3-4-5 kink, and Mut2-4-5kink are
not consistent with a typical intramolecular G-quadruplex spectra (neither parallel nor
antiparallel). These spectra are more consistent with either formation of an
intermolecular structure, are similar to the spectra for a random poly-(Gn) sequence with
non-specific associations, or are folding into a structure that is not identifiable at this time
(but is not a monomeric intramolecular G-quadruplex).
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CD spectra for WT K-ras (30mer) and mutants Mut3-4-5Kink, Mut1-3-45kink, Mut5X15-22, Mut2-4-5kink, promoter sequences in 130 mM [K+]
BPES buffer at pH 7.0.

The results of the DSC and CD experiments present a consistent picture regarding
the structure and stability of the WT and 19 mutant model G-quadruplex forming K-ras
promoter oligonucleotides. We have previously found that the WT sequence folds into at
least two unique structural quadruplexes with different thermal stabilities. We have also
shown that mutants Mut4-5, Mut4-5X15-22, Mut5, and Mut5X15-22, which have G→A
mutations in Runs 4 or Runs 5 exhibit thermal stabilities that are similar to two
conformers present in the WT solution however there are differences between the relative
concentrations of folded species in Mut5 when comparing to the WT melting profiles.
All the G→A mutations were made in order to simplify the explanation of the
predominant conformers in equilibrium in dilute solutions or to validate the use of a
“kink “or large lateral loop as a possible stable G-quadruplex folding characteristic.
Presumably, the implemented base mutations effect the stabilities and change the folding
topologies of the G-quadruplexes present in equilibrium by one of two mechanisms 1) a
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percentage of the G-quadruplex structures involve the incorporation of these “kinked” out
bases in their folding topology, or 2) the mutation from a G→A base effects the lateral
loop conformation and alters the overall stability of the structure in comparison to those
found within the WT oligonucleotide solutions. Either one of these mutations may cause
a decrease in G-quadruplex structure stability and shift the equilibrium of folded
structures to favor a different predominant folding topology.
Because the K-ras WT promote sequence is highly rich in guanines, a large
number of mutants were created to probe a broad range of potential folding
conformations. The large number of mutants created (19) in this study were selected for
further analysis based upon their CD spectra and their DSC thermal melting profiles. A
number of these mutants exhibited CD spectra that were not consistent with previously
reported spectra for the formation of intramolecular G-quadruplexes and therefore were
not the primary focus of this study. Those mutants that exhibited CD spectra consistent
with previously reported CD results and demonstrated DSC Tm values that were similar
to those reported in Chapter 4 for the WT or had melting profile(s) that were > 50°C were
studied further. Of these 19 total mutants, 8 of the mutants that exhibited the highest
melting temperatures were selected to perform DMS footprinting experiments and were
modeled using molecular modeling techniques. Not all figures are shown for the mutant
K-ras constructs, only the figures (DSC, DMS and modeling) for those exhibiting spectra
similar to those previously reported for well characterized G-quadruplexes are exhibited
here to simplify the results. The Tm values for the WT K-ras 30mer independent melting
profiles as well as the 19 mutants are listed in Table 1.
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Table 5.2

DSC derived Tm values for the WT and Mutant K-ras promoter sequences.
DSC

Sequence

CD

DMS

Sequence

Tm1

Tm2

# Kink

Q-Plex

Topology

Q-Plex

WT

58.97

71.59

No

Yes

Parallel

Yes

Kras Mut8A

56.99

68.01

No

Yes

Mixed

-

Kras Mut8T

57.28

79.32

No

Yes

Mixed

-

Mut 1-5

26.4

35

Yes/2

No

-

-

Mut 1-5X15

27.2

-

Yes/2

No

-

-

Mut 1 X8-15-22

31.9

43.4

Yes/1

No

-

-

Mut 2-5 (mt1)

53

-

No

No

Parallel

No

Mut 2-5 X8-15-22 (mt2)

54

-

No

Yes

Mixed

No

Mut 3-5 (mt3)

39.4

53

Yes/1

No

Mixed

No

Mut 3-5 X8-15-22 (mt4)

40.8

-

Yes/1

No

-

No

Mut 4-5 (mt5)

55.6

69.7

Yes/1

Yes

Parallel

Yes

Mut 4-5 X15-22 (mt6)

54.5

69.5

Yes/1

Yes

Parallel

Yes

Mut 5 (mt7)

57.2

69.9

Yes/1

Yes

Parallel

Yes

Mut 5 X15-22 (mt8)

56.7

69.8

Yes/1

Yes

Parallel

Yes

Mut 2-4-5kink

30.4

-

Yes/3

No

-

-

Mut 3-4-5 kink

32.1

-

Yes/3

No

-

-

Mut 1-3-4-5 kink

21.9

30.9

Yes/3

No

-

-

Kras Mut5 Short

62.17

-

Yes/1

Yes

Parallel

-

Kras Mut5 X15-22 Short

61.16

-

Yes/1

Yes

Parallel

-

22AA

49.38

-

No

No

-

-

Kras Mut 2-5X15A

50.92

-

No

No

-

-

Kras Mut 2-5X15T

52.71

-

No

No

-

-

KRAS MUT 2-5 X8-15-
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DSC thermal melting profiles for the Mut2-5 and Mut2-5X15-22 K-ras promoter
region oligonucleotide sequences as well as a model for the minimized structure for a
single intramolecular G-quadruplex structure for each of the mutants are shown in Figure
5.4. The Mut2-5 and Mut2-5X15-22 thermograms are comprised of a single asymmetric
peak that has been fit for a single “two state” transitions with Tm values of 53.0 °C and
54.0 °C respectively. The Tm values and the minimized structures for the Mut2-5 and
Mut205X8-15-22 are nearly identical. The only difference between these two mutants is
that bases G15 and G22 have been mutated to A15 and A22.
The DSC thermal melting profiles for the Mut3-5 and Mut3-5X15-22 K-ras
promoter region oligonucleotide sequences as well as a model for the minimized structure
for a single intramolecular G-quadruplex structure for each of the mutants are shown in
Figure 5.5. These constructs were made by mutating Run 3 of guanines within the WT
sequence, again the only difference between these two mutants (like Mut2-5 and mut 25X8-15-222) is that G15 and G22 have been mutated to A15 and A22. Mut 3-5 is best
fit for only two independent “two-state” transitions with Tm values of 39.4 °C and 53.0
°C. The Mut3-5x15-22 thermogram is comprised of a single asymmetric peak that has
been fit for a single “two state” transitions with Tm value of 40.8 °C.
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Figure 5.4

(Top left)DSC thermogram for the thermal denaturation of the K-ras
mutant Mut2-5 26mer sequence in 130 mM [K+] BPES buffer at pH 7.0.
The raw excess heat capacity has been deconvoluted into a single “two
state” processes. The solid black curve is for the raw excess heat capacity
superimposed with the composite curves (dashed pink lines) for the
independent “two-state” transition. (Top right) Schematic representation of
the proposed Mut2-5 folding topology. Depicted is a side view of the of the
G-tetrad core with large lateral loops to the left and right. (Bottom Left)
DSC thermogram for the thermal denaturation of the K-ras mutant Mut25X8-15-22 26mer sequence in 130 mM [K+] BPES buffer at pH 7.0. The
raw excess heat capacity has been deconvoluted into a single “two state”
processes. (Bottom right) Schematic representation of the proposed Mut25 folding topology. Depicted is a side view of the of the G-tetrad core with
large lateral loops to the left and right.
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Figure 5.5

(Top Left) DSC thermogram for the thermal denaturation of the K-ras
mutant Mut3-5 26mer sequence in 130 mM [K+] BPES buffer at pH 7.0.
The raw excess heat capacity has been deconvoluted into two “two state”
processes. The solid black curve is for the raw excess heat capacity
superimposed with the composite curves (dashed pink lines) for the two
overlapping “two-state” transitions. (Top right) Schematic representation of
the proposed Mut3-5 folding topology. Depicted is a side view of the of the
G-tetrad core with large lateral loops to the left and above. (Bottom Left)
DSC thermogram for the thermal denaturation of the K-ras mutant Mut35X15-22 26mer sequence in 130 mM [K+] BPES buffer at pH 7.0. The raw
excess heat capacity has been deconvoluted into a single “two state”
processes. (Bottom right) Schematic representation of the proposed Mut35X15-22 folding topology. Depicted is a side view of the of the G-tetrad
core with large lateral loops to the left and front of the structure.
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The DSC thermal melting profiles for the Mut4-5 and Mut4-5X15-22 K-ras
promoter constructs as well as a model for the minimized structure for a single
intramolecular G-quadruplex structure for each of the mutants are shown in Figure 5.6.
These constructs were made by mutating Run 4 of guanines within the WT sequence,
again the only difference between these two mutants (like Mut2-5 and mut 2-5X8-15222) is that G15 and G22 have been mutated to A15 and A22. The Tm values and the
minimized structures for the Mut2-5 and Mut205X8-15-22 are nearly identical.

Mut 4-5

and Mut4-5X15-22 are best fit for two independent “two-state” transitions with Tm
values of 55.6 °C and 69.7 °C, 54.5 °C and 69.5 °C respectively. The Tm values and
relative concentrations for each of these independent melting transitions are similar those
reported for the WT K-ras promoter sequence in Chapter 4 and in Table 1.
DSC thermal melting profiles for the Mut5 and Mut5X15-22 K-ras promoter
constructs as well as a model for the minimized structure for a single intramolecular Gquadruplex structure for each of the mutants are shown in Figure 5.7. These constructs
were made by mutating Run 5 of guanines within the WT sequence, again the only
difference between these two mutants (like Mut2-5 and mut 2-5X8-15-222) is that G15
and G22 have been mutated to A15 and A22. The Tm values and the minimized
structures for the Mut2-5 and Mut2-5X8-15-22 are nearly identical.

Mut 5 and

Mut5X15-22 are best fit for two independent “two-state” transitions with Tm values of
57.2 °C and 69.9 °C, 56.7 °C and 69.8 °C respectively. The Tm values for each of these
independent melting transitions are similar those reported for the WT K-ras promoter
sequence in Chapter 4 and in Table 1 and are also similar to those exhibited by Mut4-5
and Mut4-5X15-22.
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Figure 5.6

(Top left) DSC thermogram for the thermal denaturation of the K-ras
mutant Mut4-5 26mer sequence in 130 mM [K+] BPES buffer at pH 7.0.
The raw excess heat capacity has been deconvoluted into two “two state”
processes. The solid black curve is for the raw excess heat capacity
superimposed with the composite curves (dashed pink lines) for the two
overlapping “two-state” transitions. (Top right) Schematic representation of
the proposed Mut4-5 folding topology. Depicted is a top view of the of the
G-tetrad core with large lateral loops to the right and the kink in the lower
left corner. (Bottom Left) DSC thermogram for the thermal denaturation of
the K-ras mutant Mut4-5X15-22 26mer sequence in 130 mM [K+] BPES
buffer at pH 7.0. The raw excess heat capacity has been deconvoluted into
a single “two state” processes. (Bottom right) Schematic representation of
the proposed Mut4-5X-15-22 folding topology. Depicted is a top view of
the of the G-tetrad core with a large lateral loop to the right and the kink in
the lower left corner..
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Figure 5.7

(Top left) DSC thermogram for the thermal denaturation of the K-ras
mutant Mut5 26mer sequence in 130 mM [K+] BPES buffer at pH 7.0.
The raw excess heat capacity has been deconvoluted into two “two state”
processes. (Top right) Schematic representation of the proposed Mut5
folding topology. Depicted is a top view of the of the G-tetrad core with
large lateral loops to the right and the kink in the lower left corner. (Bottom
Left) DSC thermogram for the thermal denaturation of the K-ras mutant
Mut5X15-22 26mer sequence in 130 mM [K+] BPES buffer at pH 7.0. The
raw excess heat capacity has been deconvoluted into a single “two state”
processes. (Bottom right) Schematic representation of the proposed
Mut5X15-22 folding topology. Depicted is a top view of the of the G-tetrad
core with a large lateral loop to the right and the kink in the lower left
corner.
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Table 2 lists the energy minimization values calculated for five of the
conformations for the WT (described in Chapter 4) and the eight mutant constructs that
were chosen based upon CD and DSC results. Highlighted in green are the minimization
energies obtained for the WT conformations 1234 and 1245, these conformations were
predicted in Chapter 4 to be two of the possible (and most stable) conformations present
in the ensemble of folded G-quadruplex structures. The values calculated for the WT are
as a whole greater than those calculated for the eight mutants which could be attributed in
part to the model sequence length. The WT models include 30 bases whereas the mutant
constructs were shortened to 26 bases for simplification. The calculated Total energies
for Mut4-5, Mut4-5X15-22, Mut5, and Mut5x15-22 are highlighted in blue in Table 2.
These minimization energies indicate that these four structures are the most stable as
described by modeling methods. These results are consistent with the DSC and CD
indicating these may be the predominant folded conformers with the ensemble of folded
species in equilibrium within the K-ras WT promoter sequence.
DMS footprinting was used in order to determine which guanines in the entire Grich region of DNA within the Kras promoter were involved in Hoogsteen base pairing
and tetrad formation. In the absence of KCl, there is not stable G-quadruplex formation
and DMS is able to label all guanines of the sequence. Upon the addition of 100 mM
KCl, if a stable G-quadruplex forms, bases involved in tetrad formation are protected and
no band is visible.
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Table 5.3

Molecular modeling derived energy minimization values for the WT and
eight mutant K-ras constructs.
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Figure 5.8

DMS footprinting gel electrophoresis histogram with an without the
presence of KCl.

The full length wild-type sequence demonstrates a clear pattern of protection, but
not of only one isomer (Figure 5.9); this is expected following the DSC and CD data
indicating the existence of multiple species. Analysis of the histograms from the
footprint demonstrates protection of guanines in the most 5’ three runs of guanines (Runs
1-3) a lack of involvement in the Run 4, and an equilibrating use of the most 3’ run of
five guanines (Run5) with a predominance of using the middle three guanines.
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Several mutations were studied in order to isolate individual species and confirm
the predominant isoform. Mutants 1 and 2 knocked out the ‘kinked’ guanine run (Run 2)
both with and without single guanines at positions 15 and 22, respectively. Mutants 3
and 4 abrogated the middle most run of guanines (Run3) again with and without G-to-T
mutations at positions 15 and 22. All four of these mutations knocked out G-quadruplex
formation within the Kras promoter sequence, with no protection pattern evidenced in the
presence of KCl.
In contrast, G-to-T mutations at the 3’ end of the sequence did not destroy
formation of the higher order DNA secondary structure. Moreover, these mutations,
especially as evidenced by mutants 5 and 6 where the apparently uninvolved run D was
replaced, more clearly define a clean pattern of G-quadruplex formation involving the
‘kinked’ run B. The final set of two mutants, 7 and 8, highlight the likely minor species
by knocking out run A and forcing the use of run D. There is still a clear protection
pattern evident with this series, again involving the kinked run B. To further demonstrate
the formation of the stable G-quadruplexes occurs in the presence of the K+, a simple CD
study was performed with the 8 mutants analyzed by DMS footprinting methods. The
CD spectra was taken for the WT and 8 mutants in the absence of any salt (water only),
the presence of 100 mM NaCl (no K+), and the presence of 100 mM KCl, as seen in
Figure 5.9. We have previously reported on the relationship between ionic strength and
stability of DNA higher order structures (12, 13, 16-18). These CD data support that in
the absence of salt or in the presence of NaCl (as opposed to KCl) the sequences do not
exhibit the same structure that is observed in KCl (19-21).
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Figure 5.9

CD spectra for the WT K-ras promoter sequence and eight mutant
constructs. The top panel demonstrate the lack of typical CD spectra for
any folded species in the absence of salt. The middle panel demonstrates
the CD spectra for eight mutants in 100 mM NaCl. The spectra in NaCl are
attenuated in comparison to those seen in KCl. The lower panel
demonstrates that in 100 mM KCl the spectra for the WT and eight mutants
is consistent with those obtained throughout this study.
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Discussion
Prior to 2006 there were no reports regarding the structure and stability of the WT
K-ras guanine rich promoter region sequence. Further investigation of the WT K-ras
promoter sequence revealed that the guanine rich promoter region could potentially form
a stable higher order G-quadruplex DNA structure (Chapter 4). In order for the K-ras
WT promoter sequence to form a stable G-quadruplex it must necessarily incorporate a
combination of large lateral loops or “kinks” in the G-quadruplex backbone, which by
previous reports would suggest a reduced ability for this region to form a stable gquadruplex. We present here a more in depth characterization of the K-ras WT promoter
region purine rich sequence with the use of 19 model constructs that were created in
order to simplify the number of folded species exhibited by the WT sequence and to
potentially assign folding topologies to the two independent melting species described by
DSC data. The use of multiple biophysical and thermodynamic techniques all provide
evidence for formation of stable G-quadruplex structure by the K-ras WT and at least 4
mutant promoter region sequences.
Out of the 19 mutants creates 8 mutants exhibited CD spectra that were similar, or
had characteristics that were somewhat similar, to those reported previously for an
intramolecular G-quadruplex structure. Mut2-5, Mut2-5X8-15-22, Mut3-5, and Mut35X15-22 all exhibit CD spectra that are not consistent with that for a typical
intramolecular parallel or antiparallel G-quadruplex structure however these spectra were
unique and could be interpreted as having a mixture of mixed parallel/antiparallel
structure formation. K-ras Mutants Mut4-5, Mut4-5X15-22, Mut5, and Mut5X15-22 all
exhibited CD spectra that were consistent with the CD spectra reported for the WT K-ras
G-quadruplex as well as the c-MYC and Bcl-2 WT G-quadruplex forming sequences
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(Chapter 4). The presence of large endothermic denaturation peaks and the relative Tm
values (>50.0 °C) obtained from our DSC experiments indicate these 8 mutants form
stable higher order structural motifs that are not the result of non-specific guanine
interactions. Tm values of (>50.0 °C) indicate that some sort of higher order structure is
being formed in the solution (ie. hairpin, G-quadruplex, G-wire, etc).
DSC results previously reported for the K-ras WT 30mer demonstrate that the WT
construct is very stable and is best fit for two overlapping independent “two state”
melting transitions with Tm values of 58.97 °C and 71.59 °C, meaning there are at least
two independent folded conformers in solution. Mutation of the first run of guanines in
the WT results in a destabilization of the G-quadruplex structures (as seen in Table 1)
therefore we can assume that the first run of guanines must be incorporated into the K-ras
G-Quadruplex structures.
The melting profiles for the Mut2-5, Mut2-5X8-15-22, and Mut3-5X15-22 all
indicate the presence of a single lower melting conformer whose structure could be
associated with that of the lowest melting species in the WT solution. Mut3-5 exhibited
two independent melting profiles, however, the lower melting profile was the
predominant profile suggesting that a majority of the structures in solution exhibit similar
folding topologies. These mutants were created by either mutating the second or the third
run of guanines to adenines in comparison to the WT. From our previous K-ras WT and
mutant studies, reported in Chapter 4, we hypothesized that Run 2, involving a kinked out
T7 base, must be included in the formation of one of the folded species in the WT
sequence. Mutation of Run 2 guanines in mutants Mut2-5 and Mut2-5X8-15-22
demonstrate similar results to those seen with Mutants 8A in Chapter 4. The models for
these two mutants seen in Figure 5.4 indicate their structures are nearly identical and are
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not affected by mutations at bases G15 and G22, however one explanation for the low
Tm values or the lower stability of these mutants could be related to the incorporation of
3 large lateral loops. By mutating Run 2 to adenines these bases are forced to be in a
lateral loop rather than in the G-quadruplex, forcing these structures to form 6:4:4 loop
structures (6 base loop, 4 base loop, 4 base loop). It is obvious from these results that
mutating Runs 2 or Runs 3 causes a notable decrease in stability of the folded structures
in solution and that these runs of guanines are both necessary to form a stable Gquadruplex structure from the WT sequence.
The melting profiles for the Mut4-5, Mut4-5X8-15-22, Mut5, and Mut5X15-22
all demonstrate two independent melting profiles suggesting there are at least two
different folded species in solution The melting temperatures of these four mutants were
very similar (almost identical) to those exhibited by the WT, as seen in Chapter 4. These
mutants were created by either mutating the fourth or the fifth run of guanines to
adenines in comparison to the WT. From our previous K-ras WT and mutant modeling
studies, reported in Chapter 4, we demonstrate those constructs that involved a Run 2
(with the kink) and runs 4 or 5 had the lowest minimization energies. The models and
DSC thermograms for Mut4-5 and Mut4-5X15-22 shown in Figure 5.6 suggest their
structures are nearly identical and are not affected by mutations at bases G15 and G22,
The G-tetrads core is stacked and planar, consistent with the models for the WT1235
conformer. The models and DSC thermograms for Mut5 and Mut5X15-22 shown in
Figure 5.7 suggest their structures are nearly identical and are not affected by mutations
at bases G15 and G22, The G-tetrads core is stacked and planar, consistent with the
models for the WT1235 conformer. There are minor differences between the
thermograms for Mut5 and Mut5X15-22, these possibly associate with the concentration
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of the solutions. It is obvious from these results that Runs 4 or 5 can either be mutated or
not included in the structure of the most stable conformers in the K-ras WT.
To further probe whether stable G-quadruplex structures were being formed, in
addition to CD techniques, DMS footprinting was employed. DMS footprinting results
indicate that all guanines exhibit at least partial cleavage in Mut2-5, Mut2-5X8-15-22,
Mut3-5, and Mut3-5X15-22. These results support that these mutants do not form a
substantial amount (if any) of stable G-quadruplex structures, however additional folded
structures or guanine association may occur.
Gel electrophoresis results (data not shown) show the presence of many high
molecular weight bands that are indicative of intramolecular structures. These could be
the result of G-wire formation or a number of guanine interactions occurring between
multiple strands.
DMS footprinting results confirmed that Mut4-5, Mut4-5X8-15-22, Mut5, and
Mut5X15-22 formed stable G-quadruplexes with cleavage patterns that were consistent
with those exhibited by the WT. There are very clear protection patterns evident for
these mutants involving the Run 2 kink in their structures. This indicates that these
sequences form stable G-quadruplexes consistent with those formed in the WT. In the
presence of KCl the full length wild-type sequence demonstrates a clear pattern of
protection, we see only a few faint cleavage bands, which indicate the formation of more
than one stable G-quadruplex conformation as seen in Figure 5.9 which is consistent with
the DSC and CD data indicating the existence of multiple species. Analysis of the
histograms from the footprint demonstrate that the guanines exhibiting the most
protection in the WT are the Runs 1,2,and 3, which the fourth run exhibits the most
cleavage (therefore a lack in involvement in G-quadruplex formation) and to a lesser
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cleavage extent the fifth run of guanines. Also from the DMS footprinting we can
resolve that the first and last guanines in the 3’ run (total of 5) are cleaved moreso than
the central 3, indicating that G25, G26, and G27 are the predominant guanines involved
in the G-quadruplex formation (which is associated with K-G22Mut2 in Chapter4).
The energy minimization values for each of the 8 mutants and the WT present a
consistent picture regarding the DSC, CD, and DMS footprinting results. The primary
importance of the modeled K-ras G-quadruplex structures is that they provide a
representative interpretation for potential biological targets for anti-cancer therapeutics.
Molecular modeling studies provide insight and reasonable alternatives to difficult
physical experiments. Obtaining crystal or NMR structures of these G-quadruplex motifs
can be very difficult and may not represent the actual structures as accurately as they
exist in solution. These modeling structures are truly just “models” and are not as
reliable as physical experimental data, however they provide a insight to the overall
stability of one structure relative to another.
The G-rich K-ras promoter sequences are very complex in comparison to the
more simple c-MYC and Bcl-2 G-rich promoter sequences.
From our biophysical characterization of the K-ras WT and mutant promoter
sequences we can make draw a number of conclusions: 1) The most stable G-quadruplex
motifs that form must necessarily incorporate Run 2 of guanines which involves a T7
kink. 2) Run 1 and Run 3 must also be incorporated in the stable G-quadruplex
formation. We hypothesize that the incorporation of these two runs allows a more
compact G-quadruplex structure to form. With the involvement of runs 1, 2, and 3, the
number of bases forced into the lateral loops of the structure are (1) single T base. These
short lateral loop lengths may facilitate in the tight packing of the G-tetrads. 3) Run 4 or
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Run 5 of guanines may or may not be incorporated into the G-quadruplex structure.
Either run 4 or run 5 can be included in the formation of stable G-quadruplex structures
exhibited by these 4 mutants and the WT. 4) The minimized structures WT 1234 and
1235 (from Chapter 4) correlate well with the data presented here for the series of K-ras
mutant promoter sequences.
We have shown that the WT K-ras promoter sequence can be best described as an
ensemble of multiple stable higher order G-quadruplex DNA motifs in dilute solution.
Under these conditions the interaction G-quadruplex DNA with novel ligands or proteins
that are able to drive the formation of the G-quadruplex structure would be invaluable to
the field of higher order DNA structural studies. Small molecules that are able to drive
the formation of G-quadruplex structures, specifically K-ras, would allow for the
advancement of anti-cancer drugs that can modulate the transcription and expression of
genes, especially oncogenes. By understanding and characterizing the G-quadruplex and
i-Motif structures that form within the K-ras promoter region, novel drugs that
specifically target these higher order structures could be designed. The ability to
selectively exploit specific G-quadruplex structures within the K-ras promoter region
may provide new treatments for pancreatic cancers and reduce unwarranted side effects
that are observed with current non-specific treatments.
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CHAPTER VI
BIOPHYSICAL CHARACTERIZATION OF THE POLYPYRIMIDINE RICH K-RAS
PROMOTER SEQUENCE: FORMATION OF AN INTRAMOLECULAR
I-MOTIF ENSEMBLE
Abstract
i-Motif-forming sequences are present in or near the regulatory regions of >40%
of all genes, including known oncogenes. We report here the results of the first study
regarding the structure and stability of the polypyrimidine sequence found in the human
K-ras promoter region. We have performed a preliminary biophysical characterization of
the ensemble of proposed i-Motif structures formed by the WT and two model (mutant)
polypyrimidine sequences. Circular dichroism results demonstrate that the WT sequence
can adopt multiple ‘‘i-motif-like,’’ classical i-motif, and single-stranded structures as a
function of pH. At pH 5.0 and 6.0 the WT K-ras sequence exhibit classical i-Motif
signatures that are consistent with those previously reported for the WT and mutant cMYC i-Motifs at pH 5.0. The relatively less structured species in solution at a pH of 7.0
exhibit spectra that are more consistent with those for a poly d(Cn). CD results for the
two mutant polypyrimidine sequences are consistent with only “i-motif like” or singlestranded structures at all three pHs. The proposed ensemble of three folded
conformations for the WT K-ras polypurine promoter sequence are very stable.
Differential Scanning Calorimetry results for the WT K-ras promoter sequence
demonstrate an equilibrium mixture of at least three folded conformations with Tm
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values of 49.3 °C, 58.4 °C, and 64.1 °C at pH 5.0. The results of this study are
consistent with those previously reported for the mutant c-MYC 23mer promoter region
i-Motif DNA structures.
Introduction
Tetraplex DNA structures, e.g. intermolecular and/or intramolecular Gquadruplex and i-Motif structures have been known for some time (1, 2). C-rich
sequences located within 1 kb upstream of approximately 40% of all genes (including
more than 50% of the known oncogenes) may form intramolecular i-Motif structures. A
possible role for these structures in gene regulation represents an emerging area in
nucleic acids research (3). It has been proposed that the expression of several oncogenes
may be downregulated by the binding of small molecules that can stabilize either Gquadruplex or i-Motif DNA structures thus creating a “silencer element” (4-8). The
majority of studies performed on non-B form DNA structures in oncogene promoter
regions have focused on the G-quadruplex due to its inherent structural stability at neutral
pH. Numerous studies have focused on determining the folding topologies for Gquadruplex forming sequences, and explored the interactions of small molecules and
DNA binding proteins with G-quadruplex motifs (9-13). In comparison, relatively few
studies have been done on the complimentary C-rich i-Motif forming strand.
Because of the duplex nature of DNA in vivo, investigating only the single
stranded G-quadruplex structure represents an incomplete picture of the biologically
relevant gene promoter target. We recently reported the results of a computational study
in which theoretical structures for the c-MYC nuclease hypersensitivity element (NHE)
and c-MYC-NHE complexes with TMPyP4 were described (14). The complete NHE was
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proposed as a new target for drug binding as it provides new binding pockets in the
interface between the G-quadruplex and i-Motif components. To better understand gene
regulation, the biochemistry and biophysics of the i-Motif forming polypyrimidine strand
(15, 16) of the c-MYC (or other oncogene) promoter region and/or the i-Motif component
of the complete NHE must be better characterized. To date, the majority of the studies on
i-Motif DNA have focused on the formation and stability of a few model intermolecular
and intramolecular i-Motif structures (15-22). A few studies have explored the impact of
solution conditions (e.g. pH, cation, etc.) on the formation and stability of intramolecular
i-Motif structures (15, 23-27). All of these studies suggest that formation of an
intramolecular i-Motif is favored at slightly acidic pH where the cytosines are hemiprotonated (cytosine N3 pKa~4.58) (28).
In this study, we have performed a preliminary biophysical characterization of the
WT and two mutant K-ras pyrimidine rich promoter sequences using DSC and CD. The
WT polypyrimidine sequence is found to exist in solution as an ensemble of
intramolecular i-Motifs at a pHs of 5.0 and 6.0 and “i-Motif like” at pH 7.0. The two
mutant sequences were found to exist in an ensemble of “i-Motif like” structures at pHs
of 5.0 and single stranded at pH 6.0 and 7.0. These two mutant sequences are not
predicted to be the most plausible conformations in the ensemble of the i-Motif structures
formed within the WT K-ras polypyrimidine promoter sequence.
Materials and Methods
Lyophilized deoxy-oligonucleotide was obtained from Oligos Etc. (Wilsonville,
OR, USA). The model oligonucleotides were the complimentary polypyrimidine rich
regions of the WT K-ras promoter sequence and two mutant C→A constructs that were
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synthesized to simplify the number of possible folding topologies exhibited by the K-ras
WT sequence. The mutant oligonucleotide sequences differ from the WT sequence in
that three C→A substitutions at C5, C6, and C8 (MUT2-5) or 5 C→A substitutions at C5,
C6, C8, C15, and C22 (MUT2-5X8-15-22) have been incorporated as shown in Scheme
1. The complimentary polypurine rich sequences are also shown in Scheme 1 to indicate
mutations made in previous studies involving the K-ras promoter region sequences
(Chapter 5). DNA samples were prepared by dissolving the oligonucleotide into 1 mL of
.130 M [K+] BPES at three different pH values of 5.0, 6.0. and 7.0. This stock solution
was exhaustively dialyzed against two changes of the same buffer (24 h each) at 4 °C.
DNA concentrations were verified using UV-vis spectroscopy and a molar extinction
coefficient of ℇ260 of 235200 M-1 cm-1, 220500 M-1 cm-1, and 234100 M-1 cm-1 for the
WT, Mut2-5, and Mut2-5X8-15-22 i-Motif constructs, respectively. The molar extinction
coefficient was determined using a nearest neighbor calculation (36).
Table 6.1

The WT K-ras polypurine and polypyrimidine G-quadruplex and i-Motif
forming sequences.

G-RICH K-ras WT
G-RICH Kras Mut 2-5
G-RICH KRAS MUT 2-5 X8-15-22

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
5'- G G G C G G T G T G G G A A G A G G G A A G A G G G G G A G 3'
5'- G G G C T T T T T G G G A A G A G G G A A G A G G G
3'
5'- G G G C T T T T T G G G A A T A G G G A A T A G G G
3'

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
C-RICH K-ras WT i-Motif
5'- C C C G C C A C A C C C T T C T C C C T T C T C C C C C T C 3'
C-RICH Kras Mut 2-5 i-Motif
5'- C C C G A A A A A C C C T T C T C C C T T C T C C C
3'
C-RICH KRAS MUT 2-5 X8-15-22 i-Motif 5'- C C C G A A A A A C C C T T A T C C C T T A T C C C
3'

Results
We have previously reported on the structure and the stability of a mutant i-Motif
forming oligonucleotides under a variety of solutions conditions, including a range of pH
values. The gross solution structure of the WT K-ras 30mer polypyrimidine construct
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was also determined to be highly dependent on pH by both DSC and CD methods.
Figure 6.1 shows representative CD spectra for the WT K-ras 30mer oligonucleotide in
130 mM [K+] BPES solutions at pHs of 5.0, 6.0, and 7.0.
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Figure 6.1

Circular dichroism spectra of the WT K-ras 30mer i-Motif construct in 130
mM [K+] BPES. Typical CD spectra are shown for pH 7.0 (green line), pH
6.0 (blue line), and pH 5.0 (black line). The CD spectrum for the i-Motif
sequence at pH 5.0 and 6.0 shows the classic i-Motif signature with a
characteristic maximum in molar ellipticity at approximately 288nm and a
characteristic minimum in molar ellipticity at approximately 260nm.

The classic i-Motif CD signature is observed in the pH 5.0 and 6.0 solutions for
the WT K-ras 30mer construct (21, 29). At pH 7.0, the CD spectrum shows some
additional structure, presenting a CD signature that is between the reported single strand
spectrum and the classical i-Motif spectrum seen at pH 5.0. This result is consistent with
previous observations that hemi-protonation of cytosine bases favors formation of the iMotif structure, and that i-Motif formation is dependent on solution pH (2, 20). Figure 2
shows the representative CD spectra for the WT K-ras 30mer and the K-ras mutants 2-5
and 2-5X8-15-22 superimposed with the spectra for the mutant c-MYC 23mer i-Motif all
in 130 mM [K+] BPES solution at pH of 5.0.
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Circular dichroism spectra of the WT K-ras 30mer and the K-ras mutants
2-5 and 2-5X8-15-22 superimposed with the spectra for the mutant c-MYC
23mer i-Motif 130 mM [K+] BPES. The CD spectra for the WT K-ras and
mutant c-MYC sequences show the classic i-Motif signature with a
characteristic maximum in molar ellipticity at approximately 288nm and a
characteristic minimum in molar ellipticity at approximately 260nm. The
CD spectra for the two mutant K-ras 26mer constructs show a “i-Motif
like” signature with an attenuation at both the maximum molar ellipticity at
approximately 288nm and a minimum molar ellipticity at approximately
260nm in comparison to the typical i-Motif signature.

It should be noted here that in each pH range, the mutant c-MYC sequence must
be represented as an ensemble of folded structures existing in equilibrium. The CD
spectrum obtained at each pH is the concentration weighted average of the CD spectra for
the individual folded species present in solution at the experimental pH.
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Circular dichroism spectra of the mutant K-ras 26mer i-Motif constructs in
130 mM [K+] BPES. Typical CD spectra are shown for pH 7.0 (green
line), pH 6.0 (blue line), and pH 5.0 (black line). A) The CD spectrum for
the Mut2-5 i-Motif sequence at pH 5.0 exhibits “i-Motif like” signature
with a characteristic maximum in molar ellipticity at approximately 288nm
and a characteristic minimum in molar ellipticity at approximately 255nm.
At pH values of 6.0 and 7.0 Mut 2-5 exhibit spectra more characteristic of
an fairly unstructured poly d(Cn). B) The CD spectrum for the Mut2-5X815-22 i-Motif sequence at pH 5.0 exhibits “i-Motif like” signature with a
characteristic maximum in molar ellipticity at approximately 288nm and a
characteristic minimum in molar ellipticity at approximately 255nm. At
pH values of 6.0 and 7.0 Mut 2-5 exhibit spectra more characteristic of an
fairly unstructured poly d(Cn).

Figure 6.3 (A and B) are the representative CD spectra for the K-ras mutants
Mut2-5 and Mut2-5X8-15-22 in 130 mM [K+] BPES solution at pH values of 5.0, 6.0 and
7.0. Both mutants at pH 5.0 exhibit signatures that are “i-Motif like” maximum in molar
ellipticity at approximately 288nm and a characteristic minimum in molar ellipticity at
approximately 255nm. At pH values of 6.0 and 7.0 both mutants Mut 2-5 and Mut25X8-15-22 exhibit spectra more characteristic of an fairly unstructured poly d(Cn). In
comparison to the WT both mutant sequences exhibit CD signatures that are consistent
with mixtures of “i-motif like” or single-stranded structures at pH values of 5.0 and 6.0,
as seen in Figure 6.4 (A and B).
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Superimposed circular dichroism spectra of the WT K-ras 30mer and the
K-ras mutants Mut2-5 and Mut2-5X8-15-22 in 130 mM [K+] BPES. A) At
pH 6.0 the CD spectra for the WT K-ras sequences exhibits more of the
classic i-Motif signature. Mut2-5 and Mut2-5X8-15-22 exhibit spectra that
are more consistent with that of a less structured poly d(Cn). B) At pH 7.0
the K-raw WT and K-ras mutants Mut2-5 and Mut2-5X8-15-22 exhibit
spectra that are more consistent with that of a relatively less structured poly
d(Cn).

The structure and stability of the c-MYC mutant i-Motif forming sequence was
further explored in DSC experiments carried out at the pH values of 5.0, 6.0, and 7.0, and
at a single ionic strength of 130 mM [K+], consistent with our CD experiments. In
agreement with the CD data, the DSC results indicate that the ensemble of c-MYC
mutant i-Motif structures is strongly influenced solvent pH. Figure 6.5 shows that as the
pH is reduced from pH 7.0 to pH 5.0, the average melting temperature, a measure of
structure and stability, is increased for the WT K-ras i-Motif construct.
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DSC thermograms are shown for the thermal denaturation of the c-MYC
mutant 23mer construct in 130 mM K+ BPES buffer at 3 different pH
values of pH 5.0 (Black), 6.0 (Blue), and 7.0 (Green). The raw excess heat
capacity signal has been deconvoluted into two or three “two-state”
processes. The melting temperature(s), Tms, observed for the denaturation
of the “structured” or folded oligonucleotide increases with decreasing pH
over this pH range.

The complex nature of the DSC melting profiles (shown in Figures 6.6 and 6.7)
for the WT K-ras 30mer i-Motif constructs at pH 5.0 and 6.0 suggests the presence of
multiple folded conformers existing simultaneously in solution. The minimum number of
thermodynamically unique species in solution at each pH was determined by
deconvolution of the DSC thermograms into the minimum number of overlapping “twostate” thermal transitions required to fit the overall thermogram. Table 1 the Tm values
for the unfolding of each thermodynamically unique structure in the ensemble of folded
structures at pHs of 5.0, 6.0, and 7.0 for the WT and mutant K-ras constructs. For
example, at pH 5.0 the three structurally unique species within the WT had melting
temperatures of 49.3 °C, 58.4 °C, and 64.1 °C (Figure 6.6).
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DSC thermogram for the thermal denaturation of the WT K-ras 30mer iMotif sequence in 130 mM K+ BPES at pH 5.0. The raw excess heat
capacity has been deconvoluted into three “two-state” processes. The
uppermost curve is for the raw thermogram superimposed with the
composite curve for the three overlapping “two-state” transitions. The Tm
values for the three overlapping but independent melting transitions are,
49.3 °C, 58.4 °C, and 64.1 °C.

8

Cp (kcal/mol/°C)

7
6
5
4
3
2
1
0
10

20

30

40

50

60

Temperature (°C)

Figure 6.7

DSC thermogram for the thermal denaturation of the WT K-ras 30mer iMotif sequence in 130 mM K+ BPES at pH 6.0. The raw excess heat
capacity has been deconvoluted into three “two-state” processes. The raw
thermogram (black) is superimposed with the composite curve for the three
overlapping “two-state” transitions (grey). The Tm values for the three
overlapping melting transitions are, 28.7 °C, 36.0 °C, and 39.1 °C.
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Table 6.2

DSC derived enthalpy changes for the thermal denaturation of the higher
order structures formed by the WT and mutant K-ras polypyrimidine
promoter sequences at a range of pH values.

130mM
[K+]BPES pH 5.0

130mM
[K+]BPES pH 6.0

130mM
[K+]BPES pH 7.0

Tm1

Tm2

Tm2

(°C)

(°C)

(°C)

K-ras WT

49.3

58.4

64.1

K-ras Mut2-5

48.8

56.3

-

K-ras Mut2-5X8-15-22

47.7

55.2

-

K-ras WT

28.7

36.0

39.1

K-ras Mut2-5

24.6

38.0

-

K-ras Mut2-5X8-15-22

26.3

29.4

-

K-ras WT

14.3

-

-

K-ras Mut2-5

-

-

-

K-ras Mut2-5X8-15-22

-

-

-

c-MYC Mut 23mer*

38.1

46.6

49.5

c-MYC Mut 23mer*

21.7

32.5

-

130mM [K+]BPES
pH 5.0
130mM [K+]BPES
pH 6.0

* These data are for the mutant c-MYC 23mer i-Motif (30).
The mutant samples prepared at pH 5.0 and 6.0 were best fit with only two
transitions, whereas pH 7.0 (data not shown) were unable to be fit properly due to the
inherent lack of any higher order structure at this pH value. The DSC melting profiles
(shown in Figures 6.8 and 6.9) for the K-ras Mut2-5 and Mut2-5X8-15-22 constructs at
pH 5.0 and 6.0 are less complex than the WT and suggests the presence of multiple
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folded species existing simultaneously in solution. These folded species are less stable
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DSC thermogram for the thermal denaturation of the K-ras Mut2-5 26mer
i-Motif sequence in 130 mM K+ BPES. A) At pH 5.0 the raw excess heat
capacity has been deconvoluted into two “two-state” processes. The Tm
values for the two melting transitions are 48.8 °C and 56.3 °C. B) At pH
6.0 the raw excess heat capacity has been deconvoluted into two “twostate” processes with Tm values of 24.6 °C and 38.0 °C.
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DSC thermogram for the thermal denaturation of the K-ras Mut2-5X8-1522 26mer i-Motif sequence in 130 mM K+ BPES. A) At pH 5.0 the raw
excess heat capacity has been deconvoluted into two “two-state” processes.
Tm values for the two melting transitions are 47.7 °C and 55.2 °C. B) At
pH 6.0 the raw excess heat capacity has been deconvoluted into two “twostate” processes with Tm values of 26.3 °C and 29.4 °C.
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Discussion
The initial focus of this study was to explore the structure and stability of the WT
and two mutant K-ras polypyrimidine rich promoter region sequences under a variety of
solution conditions including a range of pH values. Our objective was to determine if
these polypyrimidine sequences were capable of forming stable i-Motif structures in
dilute solutions under a range the given of conditions. The sequences of the two mutants
were chosen based upon based upon previous experimental results obtained for the
complimentary polypurine rich sequence and our overall attempt to potentially reduce or
simplify the number of folded species that may form within the WT K-ras promoter
sequence. The complimentary guanine rich sequences of the two mutant constructs were
shown previously to fold into a structure that exhibited a single melting conformer by
DSC results (Chapter 5). In comparison to the native K-ras promoter sequence, the
number of potential cytosine-cytosine pairings has been reduced in the mutant sequence
by introducing three C→A mutations in Mut2-5 and 5 C→A mutations in Mut2-5X8-1522 (Scheme 1). Although the mutant sequence used in this study results in an ensemble
of folded structures as determined by DSC, it contains fewer significant species than
would be predicted for the native K-ras promoter polypyrimidine sequence. Our
microcalorimetric and spectroscopic studies indicate the presence of at least two unique
structures forming in the mutant sequences at pH values of 5.0 and 6.0, in comparison to
3 at both pH values for the WT (30).
In the highest pH solution, 7.0, the WT and mutant K-ras promoter sequences
appear to form lower stability folded structures having melting temperatures, Tms, below
30°C. The CD spectra obtained at neutral pH are not consistent with the signature
presented by the classical i-Motif structure (21, 30, 31). The spectra for all three of these
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constructs at pH 7.0 are best represented at a single stranded or random coil poly-d(Cn)
structure.
In the mid pH solutions, pH 6.0, the mutant K-ras promoter sequences appear to
form lower-stability folded structures with Tms below 40°C. These Tm values are
substantially greater than those observed at pH 7.0. The CD spectra obtained pH are not
consistent with the signature presented by the classical i-Motif structure (21, 30, 31). The
spectra for all three of these constructs at pH 6.0 are best represented at a single stranded
or random coil poly-d(Cn) structure. However, the larger positive molar ellipticity value
near 280 nm, in comparison to the CD signals for single stranded DNA, indicate the
presence of a slightly more intramolecular folded structure at this pH in comparison to
pH 7.0 (21, 31). In addition, the presence of large endothermic denaturation peaks in
DSC experiments done at pH 6.0 indicates that the mutant oligonucleotide sequence
forms folded structures, presumably stabilized by weaker C-C pairing between unprotonated cytosine bases.
In the lowest pH solution, 5.0, The WT the WT and the two mutant K-ras
constructs exhibit the largest molar ellipticity values, which corresponds to the pH region
in which all the cytosines would be expected to be hemi-protonated. At pH 5.0 the CD
spectra are consistent with a “classical i-Motif” higher order DNA signature indicating
the structures are most stable at this pH in comparison to pH 6.0 and 7.0 (21, 32). This
pH range includes the pKa of cytosine (pKa ≈ 4.58) (28)as well as the most stable
solution structure determined from DSC: pH 5.0. The WT K-ras construct CD and DSC
results are consistent with those previously reported for the c-MYC mutant promoter
region i-Motif. It is interesting to note that the WT K-ras polypurine promoter sequence
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exhibits higher thermal stabilities at both pH 6.0 and 7.0 in comparison to the c-MYC
mutant promoter i-Motif.
This observed increase in stability with the increase of acidity supports findings
presented on other i-Motif constructs (20, 30). The thermal stability and the number of
independently melting species (folded conformations) existing simultaneously in solution
for the WT and two mutant oligonucleotide sequence was determined using DSC at pH
5.0, 6.0, and 7.0. At pH 5.0 and 6.0 K-ras mutant thermal denaturation curves were best
modeled with two independent “two-state” melting transitions, while at pH 5.0 and 6.0,
thermal denaturation curves for the WT were best fit with three independent “two-state”
melting transitions. The number of transitions indicates the presence of at least two or
three i-Motif conformations existing simultaneously in solution, each with its own unique
melting temperature. This suggests that the WT sequence adopts an equilibrium between
at least three different “classical i-Motif” conformations in solution at pH 5.0, whereas
each of the mutants form at least two classical i-Motif” conformations in solution at this
pH.
In conclusion, we report that the K-ras WT polypyrimidine rich promoter
sequence folds into an ensemble of stable i-Motif structures at pH 5.0 and 6.0 and one
un-structured conformation at pH 7.0, under the solvent conditions studied here. The
absence of a stable classical i-Motif structure at pH values 7.0 does not minimize the
importance of these studies. Previous reports of i-Motif forming sequences have
indicated that thus far the highest pH in which a stable i-Motif was observed was 6.2 for
the Bcl-2 promoter region i-Motif (33). Clearly our results indicate that the K-ras i-Motif
forming sequence shows remarkable stability at pH 6.0 (30, 34) and further studies with a
broader range of pH values may indicate that K-ras is more stable than other i-Motif
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structures over a broader range of pH. Small molecules that are capable of driving iMotif formation under physiological conditions would be an area of great interest. In
addition, the solution conditions within the cell nucleus are very different than water.
The high protein and nucleic acid concentrations must contribute to molecular crowding
and to a medium having a very different ionic strength and different effective dielectric
constant than the oligonucleotide would experience in dilute aqueous solution. We
speculate here that the i-Motif could be stabilized at higher pH values under these
conditions in the cell’s nucleus.
We have shown that solvent pH strongly influences the stability and conformation
of the i-Motif structure and that conditions can be established where the “classical iMotif” is the predominant conformation. Under these conditions, the interaction of iMotif DNA with novel ligands or proteins that are able to drive the formation of the
“classical i-Motif” structure would be invaluable to the field of higher order DNA
structural studies. Small molecules that are able to drive the formation of classical i-Motif
structure would allow for i-Motif DNA to be studied under a wide range of conditions,
and possibly induced physiological changes capable of modulating the expression of
numerous oncogenes (11, 14, 35).
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CHAPTER VII
BIOPHYSICAL CHARACTERIZATION OF HAR1 READING FRAME
G-QUADRUPLEXES: A NON-PROTEIN CODING GENE
EXPRESSED IN THE HUMAN BRAIN
Abstract
In the human cerebral cortex, expression of HAR1 may be associated with several
neurological disorders e.g. schizophrenia, autism, and Alzheimer’s. The human HAR1
gene is highly enriched in guanine in comparison to HAR genes in other species and
contains 10 G-rich regions with the potential to form stable intramolecular Gquadruplexes. The four sequences studied here were selected for their proximity to the
HAR1F mRNA hairpin forming region. The structure and stability of these HAR1
reading frame, RF, G-quadruplexes were characterized using Differential Scanning
Calorimetry (DSC) and Circular Dichroism (CD) spectroscopy. As predicted, all of the
selected sequences form stable intramolecular G-quadruplexes. Sequence HAR1UP1
(25-mer), located 685 bases upstream from the HAR1F mRNA coding region, forms a
stable small loop G-quadruplex with a single one base “kink”. Sequences HAR1DWN1
(34-mer), HAR1DWN2 (42-mer), and HAR1DWN3 (31-mer), located 485, 577, and
670 bases downstream from the HAR1F coding region, form stable G-quadruplexes
having two or more conformations. This is the first study to address the formation of
stable G-quadruplex motifs within the RF of any gene. Our hypothesis is that HAR1 RF
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G-quadruplexes represent druggable targets for the treatment of neurodevelopment
disorders or other human brain diseases such as schizophrenia, autism, and Alzheimer’s.
Introduction
Almost two/thirds of the human genome has been sequenced and characterized as
non-protein coding DNA (1-3). In the comparing the human genome to that of other
species, e.g. chimpanzees, there are numerous non-coding regions in which there are
areas of significant substitution or single nucleotide polymorphisms (SNPs); roughly 77%
of which are (A,T) to (C,G) (3-5). Highly accelerated regions (i.e. human genomic
regions, which differ from the homologous regions in related species, due to the
evolutionary accumulation of a large number of SNPs) are often located adjacent to genes
involved in neurological development (1, 6, 7). HAR1 is a non protein coding gene
whose mRNA is expressed at elevated levels during early embryonic cortical
development and is constitutively expressed at lower levels in adults (1, 3, 6). HAR1
expression is predominantly observed in brain tissues and not in other major organs or
tissues, however the exact function of the HAR1 mRNA is currently unknown (1).
Investigation of the human accelerated regions will be invaluable in understanding the
role of evolutionary SNPs, not only in human neurodevelopment gene evolution, but in
human brain malignancies (1, 5, 6)
Reelin is a cortical patterning protein that regulates neuron and cell positioning in
the cerebral cortex during brain development and is also involved in neuronal and
neuroblast migration and maintenance in adult brains (7-12). In normal adult human
brains reelin and HAR1 are constitutively co-expressed. However, in a number of
cortical diseases the expression of both reelin and HAR1 are altered (9, 12). In patients
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with schizophrenia a 50% decrease in reelin expression is observed whereas in
Alzheimer’s patients reelin expression levels are increased by roughly 40% in the
cerebrum and cerebral cortex (2, 9).
The characterization of higher order DNA motifs, e.g. G-quadruplexes and iMotifs, that can form in purine rich or pyrimidine rich regions of oncogene promoter
sequences has been extensively reported (13-15). To date there have been no reports of
G-quadruplex structures formed outside of oncogene promoter regions. A number of Gquadruplex interactive agents have been reported to facilitate the formation and
stabilization of the G-quadruplex structure (16). Unfolding of G-quadruplex motifs by
protein specific interactions has also been reported (16). Discovering drugs that could be
used to regulate the transcription of the HAR1 gene could provide a new therapeutic
approach for a number of brain diseases (1, 10, 16, 17).
Protein coding regions or specific proteins associated with human brain
malignancies are not considered to be promising targets because they may be crucial in
additional reaction pathways or signaling cascades within the brain (1, 18). There are
numerous proteins that are active in multiple regions of the brain and disruption of their
interactions in one disease may present further negative results by effecting additional
signaling cascades. However, the HAR1 gene may be an optimal target due to its lack of
protein coding functions and relatively confined expression location. We report here a
preliminary biophysical characterization of four HAR1 reading frame polypurine
sequences.
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Materials and Methods
The HAR1 WT sequences were obtained from Oligos Etc (Wilsonville, OR). The
construct sequences synthesized were the native polypurine sequence found within the
HAR1 reading frame (Scheme 1).
Table 7.1
Sequence
HAR1 UP1
HAR1 DWN1
HAR1 DWN2
HAR1 DWN3
c-MYC
Bcl-2
K-ras

5'5'5'5'5'5'5'-

Sequences for the four WT HAR1 reading frame G-quadruplex constructs,
HAR1UP1, HAR1DWN1, HAR!DWN2, and HAR1DWN3.
1
G
G
G
G
C
A
G

2
G
G
G
G
T
G
G

3
G
G
G
G
T
G
G

4
C
C
A
G
A
G
C

5
A
T
A
C
T
G
G

6
G
G
C
G
G
C
G

7
G
G
C
C
G
G
T

8
C
G
T
A
G
G
G

9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43
G C T G G G T G G G T G G A A G G
G C C G G C C T G G G C T T T C A G G G C G A G G G
G G G C C G G G A G C T G C G G G C C G C T C C G G G G A A G C G G G
G G G G C C C G C G G T T G G G C T C C G G G
G A G G G T G G G G A G G G T G G G G A A G G T G G G G
G C G C G G G A G G A A G G G G G C G G G A G C G G G G C T G
T G G G A A G A G G G A A G A G G G G G A G

All stock solutions were prepared by dissolution of weighed amounts of
lyophilized oligonucleotide into [K+] BPES buffer at a salt concentration of 130 mM [K+]
(19). Approximately 1 mL of the oligonucleotide was exhaustively dialyzed (1000
molecular-weight cutoff membrane) with two changes of buffer solution (1 L, 24h each)
at 4°C. The concentrations of all DNA solutions were verified by UV adsorption at 260
nm using the extinction coefficients calculated from the oligonucleotide sequences using
the nearest neighbor method: 245700, 313200, 402800, and 282700 cm-1 M-1 for the
HAR1UP1, HAR1DWN1, HAR1DWN2, and HAR1DWN3 respectively (20).
Results
CD spectra for all four HAR1 WT constructs are shown in Figure 7.1. The CD
spectrum for the HAR1UP1 sequence exhibits two overlapping peaks with maximum
molar ellipticities at approximately 264 nm and 295 nm and a trough with a minimum at
approximately 240 nm.
159

15

UP1
DWN1
DWN2
DWN3

millidegrees

10
5
0

220

-5

240

260

280

300

λ (nm)

-10

Figure 7.1

Circular dichroism spectra of the HAR1 reading frame G-quadruplex
constructs in 130 mM [K+] BPES.

The HAR1UP1 CD signature is characteristic for a G- quadruplex having a mixed
parallel/anti-parallel folding topology (19). HAR1DWN1 exhibits a larger 295 nm peak
but is also considered to be a mixed parallel/anti-parallel structure. HAR1DWN2 and
HAR1DWN3 demonstrate maximum molar ellipticities that are greater at 295nm and
minimum at 240, indicative of intramolecular G-quadruplexes having less parallel and
more anti-parallel character.
Differential Scanning Calorimetry (DSC) results demonstrate that the various
G-Quadruplexes formed within the reading frame of the HAR1 gene are highly stable. In
130 mM [K+] BPES pH 7.0 solution all four HAR1 WT G-Quadruplex constructs are
best fit with two “independent two-state” melting transitions which is indicative of an
equilibrium between at least two uniquely folded conformers, as seen in Figure 7.2.
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Figure 7.2

DSC thermogram for the thermal denaturation of the HAR1 RF Gquadruplex constructs in 130 mM K+ BPES at pH 7.0. The raw excess heat
capacity for all four sequences has been deconvoluted into two “two-state”
processes. The uppermost curve (black) is for the raw thermogram
superimposed with the composite curve for the two overlapping “two-state”
transitions (dotted lines). The two curves, the raw and the fit, are virtually
indistinguishable. The Tm values for the two overlapping but independent
melting transitions are listed in Table 1.

The Tm values for all four constructs are shown in Table 1. The lower melting
conformer is the predominant conformer within the HAR1UP1, HAR1DWN1, and
HAR1DWN2 constructs whereas the higher melting conformer is the predominant
conformer within the HAR1DWN3 reading frame construct.

161

Table 7.2

Tm values for the HAR1 WT RF constructs.

Sequence
HAR1 UP1
HAR1DWN1
HAR1DWN2
HAR1DWN3

Tm1 (°C)
61.1
63.3
58.9
49.7

Tm2 (°C)
72.2
75.5
71.8
69.5

Isothermal Titration Calorimetry (ITC) was performed to evaluate the binding of
a well known G-quadruplex interactive agent, TMPyP4, to compare the affinity and mode
of binding to the HAR1 to the other well documented promoter region G-quadruplexes.
Figure 7.3 shows data from a typical ITC titration for the addition of TMPyP4 to the
HAR1UP1 WT 25mer construct. The figure shows the raw titration data, the integrated
heat data, and the best fit line for one of the three replicate titrations. The fit line shown
in Figure 7.3 is for a two independent sites model (1, 27-30). The average
thermodynamic parameters obtained for each set of replicate titrations are listed in Table
2 (Ki , ΔGi, ΔHi and -TΔSi values) for a two site model as required for each different
oligonucleotide and a single ionic strength of 130 mM [K+] BPES. The ITC results
obtained for all four WT sequence quadruplex demonstrate a binding stoichiometry of 4:1
moles TMPyP4: DNA at saturation (1, 27). The microcalorimetric integrated heat data
for the titration of the c-MYC WT quadruplex is obviously complex but can be fit within
experimental error for a binding model having at least two independent overlapping
binding processes (“exterior” or end binding and an “intercalative” binding mode).
These results are consistent with TMPyP4:c-MYC, Bcl-2, and K-ras promoter region Gquadruplex binding data (22,30).
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Figure 7.3

ITC data shown are for the addition of TMPyP4 to the HAR1UP1 25mer
construct at pH 7.0 in 130mM [K+] BPES. The integrated heat data
(points) are for a single titration experiment. The best fit nonlinear
regression line shown () is for the thermodynamic parameters obtained
using a two independent sites model, having two values for Ki, two values
for ΔHi , and two values for ni.

Table 7.3

ITC-derived thermodynamic parameters, equilibrium constants, and Gibbs
free energy change values for TMPyP4 binding to the WT HAR1 RF Gquadruplex constructs in 130 mM [K+] BPES buffer at pH 7.0.

# These data are for the interaction of TMPyP4/K-ras WT 30mer G-quadruplex (Ch.4).
* These data are for the interaction of TMPyP4/c-MYCWT 36mer G-quadruplex (22).
+ These data are for the interaction of TMPyP4/Bcl-2 WT 39mer G-quadruplex (30)
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Figure 7.4 shows data from a typical ITC titration for the addition of TMPyP4 to
the HAR1DWN2 WT 25mer construct. The figure shows the raw titration data, the
integrated heat data, and the best fit line for one of the three replicate titrations. The
HAR1DWN1, HAR1DWN2, and HAR1DWN G-quadruplex titration data are slightly
more complex. They require the use of the two independent binding sites model to fit the
thermograms for titration within expected experimental error, however, the overlapping
transition for the two distinct binding modes is greater than that of the HARUP1 therefore
the robustness of the fits for the remaining three constructs are not as good as that of the
HAR1UP1.
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ITC data shown are for the addition of TMPyP4 to the HAR1DWN2 43mer
construct at pH 7.0 in 130mM [K+] BPES. The integrated heat data
(points) are for a single titration experiment. The best fit nonlinear
regression line shown () is for the thermodynamic parameters obtained
using a two independent sites model, having two values for Ki, two values
for ΔHi , and two values for ni.
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Discussion
From the preliminary DSC and CD results we hypothesize that the Guanine rich
reading frame of the HAR1 gene, upstream and downstream of the mRNA coding region,
forms multiple stable parallel stranded G-quadruplexes that are comparable to other well
characterized oncogene promoter region G-quadruplexes. DSC has been shown to be a
valuable technique for unambiguously determining the minimum number of unique
conformations (having different thermal stabilities) which exist in equilibrium in dilute
solutions of single stranded polypurine sequences capable of forming G-quadruplexes
(8).
The HAR1 gene reading frame is highly Guanine rich and exhibits a number of
regions where 4 runs of 3 or more consecutive guanines are present. We have identified
at least 10 guanine rich sequences with the potential for forming G-quadruplexes in the
reading frame of the human HAR1 gene. This study only focuses on four of the
sequences selected for their proximity to the HAR1F mRNA hairpin forming region and
for their predicted potential to form the most stable G-quadruplexes. These folding
predictions were based upon previous studies that focused on guanine rich regions found
within oncogene promoter regions that have been reported to form these higher order
DNA structures. In order for the HAR1UP1 construct to form a stable G-quadruplex the
structure must necessarily incorporate a “kinked” out base within the G-tetrad backbone.
These kinked structures have only been recently reported and investigated. In order for
HAR1DWN1 and HAR1DWN2 to form stable G-Quadruplex motifs large lateral loops
must be incorporated into the folded structures that are similar to those exhibited by Bcl-2
and K-ras sequences.
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The ITC results present an energetic binding profile for the interaction of
TMPyP4 with the HAR1 constructs that is similar to the energetic binding profiles of
TMPyP4 with the c-MYC, Bcl-2, and K-ras (WT and mutant) promoter regions Gquadruplexes. The HAR1 constructs exhibit two distinct binding modes for TMPyP4
with a saturation stoichiometry 4:1 for TMPyP4 to DNA. The first, higher affinity,
binding mode is entropically driven where the second binding mode, with lower affinity,
is enthalpically driven. These modes were described previously as Mode 1 and Mode 2
binding, with each one of these involving two binding sites, each binding 1 mole of
TMPyP4. The relative affinities for the binding of TMPyP4 for both modes of binding
are comparable to those for the affinity of TMPyP4 to the c-MYC and Bcl-2 WT Gquadruplexes. The energetic profile for the first TMPyP4 binding mode is indicative of an
entropy driven process. One subtle difference observed was for the binding of TMPyP4
to the HAR1DWN1, HAR1DWN2, and HAR1DWN3 constructs; the binding affinity of
mode 1 binding is slightly reduced in comparison to the oncogene promoter Gquadruplexes. Also it must be noted that the overall binding curve shape is different in
comparison to those for the WT c-MYC, Bcl-2, and K-ras G-quadruplexes. The data for
these three HAR1 constructs suggest that the binding is more complex in that the binding
process occurring in both binding modes overlaps substantially and therefore it is harder
to distinguish between the two processes occurring in equilibrium with one another.
Each of the HAR1 guanine rich sequence studied here adopts at least two unique
conformations 130 mM [K+] BPES. These HAR1 G-quadruplex constructs are more
complex than those previously reported within promoter regions of various oncogenes
(i.e. c-MYC, Bcl-2, and K-ras) and their sequence composition obviously demonstrate
that non-core bases affect both quadruplex binding and stability characteristics. We have
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discussed that DSC melting profiles can be used to evaluate and/or deconvolute the
different structural species that might exist in equilibrium for a folded oligonucleotide.
The strength of this study lies in part on the correlation and /or agreement between the
DSC and the ITC data with the results previously reported for well characterized
promoter region G-quadruplexes. This study is the first to report on the higher order Gquadruplex DNA structures within a gene reading frame as opposed to being located
within a promoter region.
From this preliminary research we hope to compile and describe a set of folding
rules in which G-quadruplex structure and stability may be predicted. From these studies
we also hope to better understand the role that reading frame G-quadruplexes may play
within gene regulation especially within the human brain during development and into
adulthood. Future work to search for compounds having high selectivity and affinity for
the HAR1 RF G-quadruplexes should take advantage of the large loops and kinks that
may be involved in the binding process.
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